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ABSTRACT

EXERCISE MITIGATES THE EFFECTS OF HYPERHOMOCYSTEINEMIA
ON ADVERSE SKELETAL MUSCLE REMODELING

Lee Winchester

August 3, 2015

Background: Hyperhomocysteinemia (HHcy) is heavily implicated in diabetes
and cardiovascular disease. HHcy is known for causing inflammation and
vascular remodeling, particularly through production of reactive oxygen species
(ROS) and matrix metalloproteinase-9 (MMP-9). Although its impact on skeletal
muscle is rather unclear, HHcy is known to cause skeletal muscle weakness and
functional impairment. The impact of HHcy on inflammation makes it seem likely
that HHcy causes skeletal muscle fibrosis through induction of inflammatory
factors and destructive macrophages. Exercise has been shown to reduce
homocysteine levels and therefore, could serve as a promising intervention for
HHcy. The purpose of this study was to investigate whether HHcy causes
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skeletal muscle fibrosis through induction of inflammation and determine if
exercise can mitigate these effects.
Methods: For these experiments we used J774A.1 and Raw 264.7 macrophages
in cell culture and C57, CBS+/-, FVB, MMP-9 -/-, and CBS/MMP-9 double KO
mice for animal models. A 6 week treadmill exercise protocol was used as
intervention for HHcy. Arterial blood pressure measures were taken through tailcuff method. Hind limb perfusion was measure via laser Doppler. Plasma Hcy
estimations were measured thorugh dot blot. Measurement of skeletal muscle or
macrophage protein expression occurred through the use of western blot,
immunocytochemistry or immunohistochemistry. Levels of skeletal muscle mRNA
expression were determined through PCR and qPCR. Collagen deposition in the
skeletal muscle was measured using Masson’s trichrome staining. ROS
production in macrophages was measured using a DCFDA assay.

Results: In CBS+/- mice, increased plasma Hcy levels were associated with
decreased body weight and muscle mass, femoral artery perfusion, femoral
artery lumen diameter and oxidative metabolism. These mice displayed
increased wall to lumen ratio, mean arterial blood pressure, collagen deposition
and elevated myostatin protein expression. It was determined that CBS/MMP-9
mice did not display any of these conditions. Exercise was capable of mitigating
all of these effects in CBS +/- mice.
Skeletal muscle from CBS+/- mice had elevated markers of inflammation
and hypoxia including VEGF, iNOS, EMMPRIN, MMP-9, and IL-1β. Cell culture
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studies determined that Hcy caused macrophages to shift towards a destructive,
M1 phenotype as indicated by elevated CD40, ROS, EMMPRIN and MMP-9
production. EMMPRIN inhibition prevented induction of CD40 and ROS. In CBS
+/- mice, it was determined that HHcy causes increased elevations in F4/80 and
TNF-α expression, which are indicative of M1 macrophages. Exercise was
capable of reducing the M1 macrophage population.

Conclusions: We conclude that HHcy causes skeletal muscle fibrosis through
induction of MMP-9 and M1 macrophages. Exercise is capable of mitigating the
pathologies associated with HHcy.
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CHAPTER I
INTRODUCTION

Homocysteine (Hcy) is a non-protein forming, non-essential amino acid
that is derived from methionine. Homocysteine is normally present in healthy,
human plasma, but high levels of plasma Hcy, termed Hyperhomocysteinemia
(HHcy), has been strongly associated with diseases such as diabetes mellitus,
cardiovascular diseases and skeletal muscle dysfunction. It is well established
that HHcy is directly correlated with aortic stiffness, decreased renal function,
endothelial dysfunction and hypertension (Bortolotto et al., 1999; Givvimani,
Pushpakumar, Veeranki, & Tyagi, 2014; Naess, Nyland, Idicula, & WajeAndreassen, 2013; Sutton-Tyrrell, Bostom, Selhub, & Zeigler-Johnson, 1997;
Wiernicki, Millo, Safranow, Gorecka--Szyld, & Gutowski, 2011). However, more
recent evidence suggests that HHcy also causes damage to skeletal muscle.
Studies have shown that HHcy is strongly correlated with decreased muscle
strength and functional limitations as well as skeletal muscle damage (Miller et
al., 2000; Swart et al., 2013; S. Veeranki, Winchester, & Tyagi, 2015). Children
and animals born with a mutation that causes hyperhomocysteinemia due to the
inability to properly metabolize homocysteine display lower body weights and
decreased muscle mass compared to their healthy counterparts (Kalra, Ghose, &
Sood, 1985; Kanwar, Manaligod, & Wong, 1976).
1

Many years of research on HHcy have sought to determine the
mechanisms through which it causes these deleterious effects. The ability of
HHcy to induce high levels of reactive oxygen species (ROS) indicates that Hcy
may inflict a great deal of damage through increased oxidative stress and
inflammation (Hayden & Tyagi, 2004; Signorello et al., 2007; S. C. Tyagi,
Lominadze, & Roberts, 2005). HHcy is also known to increase the expression
and activity of matrix metalloproteinases (MMP), particularly MMP-9 (Seung Jin
Lee et al., 2012; Moshal et al., 2006; Neetu Tyagi et al., 2009). MMP-9 is an
endoproteinase that degrades components of the extracellular matrix (ECM).
This degradation of the ECM can lead to adverse remodeling in muscle tissues.
It is commonly known that macrophages play a pivotal role in the
inflammatory response and the progression of diseases such as atherosclerosis.
More recent evidence has suggested that HHcy may have an effect on
macrophage migration and function as well. Research has demonstrated that
HHcy increases macrophage expression of MMP-9, vascular endothelial growth
factor (VEGF) and monocyte chemoattractant protein-1 or MCP-1 (Kiriakidis et
al., 2003; Seung Jin Lee et al., 2012; Wang, Siow, & Karmin, 2001). The ability of
Hcy to alter the expression of certain macrophage proteins may evolve as
another central mechanism through which HHcy causes disease progression.
The concept that regular exercise provides healthful benefits and plays a
rather ubiquitous role in the prevention and reversal of many diseases is rather
concrete. However, the effect of regular exercise on HHcy is not very well
established. Recent studies have demonstrated that exercise can lower plasma
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homocysteine levels and mitigate the adverse effects of HHcy in many organs
(Hrncic et al., 2013; König et al., 2003; Neuman, Albright, & Schalinske, 2013;
Randeva et al., 2002; Vincent, Bourguignon, & Vincent, 2006). In the current
study, we investigated the effects of HHcy on skeletal muscle remodeling and
inflammation as well as the ability of exercise to attenuate these effects.
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CHAPTER II
BACKGROUND

Skeletal Muscle
Function of Skeletal Muscle
Skeletal muscle is a high-energy consuming tissue that makes up roughly
40 to 50% of the total bodyweight in the average human (Powers & Howley,
2007). It consists of very long, multinucleated cells called myocytes that are
bundled up and surrounded by connective tissues. In general, skeletal muscle
has 2 primary functions: 1) production of contractile force that provides breathing,
locomotion and postural support; and 2) thermogenesis during periods of cold
stress. For force production, depending on the basic function of the muscle it
may consist of either fast twitch (type I) fibers or slow twitch (type II) fibers
(Powers & Howley, 2007). Type I fibers are used for repetitive, low-intensity
functions, such as postural support. These fibers provide less force generation,
but are fatigue resistant and have a higher reliance on oxidative metabolism and
therefore have a greater density of mitochondria and oxidative enzymes. Type II
fibers can be further divided out into two fiber subsets: type IIx and type IIa
(Powers & Howley, 2007). Type IIx fibers are very glycolytic and produce great
contractile force, but are susceptible to fatigue due to a lower mitochondrial
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density. Type IIa fibers are an intermediate fiber type. They produce a moderate
contractile force and are more fatigue resistant than Type IIx fibers.

Anatomy and Physiology of Skeletal Muscle
The outermost layer of a skeletal muscle is the epimysium, which is a
connective tissue that surrounds the entire muscle. Inward from the epimysium is
the perimysium, which surrounds individual bundles of myocytes, called
fascicles. Inside of these fascicles are individual myocytes that are surrounded
by a connective tissue called the endomysium (Powers & Howley, 2007). Just
under the endomysium lies another protective layer called the basement
membrane. Below the basement membrane is the myocyte cell membrane,
called the sarcolemma. Within the sarcolemma lies the intracellular fluid called
sarcoplasm.
Myocytes, unlike most other cell types, contain multiple nuclei and are
striated because of contractile segments called sarcomeres. Within each
myocyte are structures called myofibrils, which contain the contractile proteins of
the muscle, called myosin and actin (Powers & Howley, 2007). On the actin
filament itself lies two additional proteins called troponin and tropomyosin, which
are used for contractile regulation. The striated regions, called sarcomeres, are
within the myofibrils and consist of areas of myosin/actin overlap, as well as an
area where myosin does not overlap with actin, called the H zone. Sarcomeres
are divided by a wall of structural proteins, which make up a region of the
sarcomere called the Z line. During contraction, with required energy coming
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from the dephosphorylation of adenosine triphosphate (ATP), Myosin heads
“cock” and form crossbridges with actin and then pivot inward towards the H
zone. This process is called the “sliding filament theory” and is evident by the
decrease in sarcomere length from Z line to Z line.
Surrounding each myofibril is a network of channels that serves as a
storage site for calcium, which is crucial for regulation of muscular contraction
(Powers & Howley, 2007). This structure is called the sarcoplasmic reticulum.
The transverse tubules are another set of channels that pass through the muscle
fiber. Each myocyte is connected to a branch of a motor neuron through a
neuromuscular junction, which serves as the site of electrochemical
transmission. Collectively, all of the myocytes that are innervated by a single
motor neuron are called a motor unit. Upon the generation of an action potential
great enough to cause contraction, the neural impulse is transmitted to the
myocyte through the neuromuscular junction and is propogated down the
transverse tubules to the sarcoplasmic reticulum, causing Ca++ to be released.
Ca++ binds to the troponin molecule, which causes a shift in tropomyosin position.
This allows for exposure of the actin active sites and myosin-actin crossbridge
formation, resulting in contraction.

Regulation of Skeletal Muscle Growth and Repair
The extracellular matrix (ECM) is a non-cellular structure that provides
physical integrity and biomechanical/biochemical support for the surrounding
cells. The ECM has two primary components denoted as the interstitial matrix
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and the basement membrane (Koeppen & Stanton, 2010). These structures are
largely made up of fibrous proteins such as collagen and elastin, which
respectively provide rigidity and distensibility. The interstitial matrix serves as a
compression support for the ECM, while the basement membrane is a fibrous
sheet that separates the surrounding cells from the connective tissues. The ECM
is a well-regulated structure that is synthesized and degraded to allow for proper
wound healing, growth and fibrosis.
The extracellular matrix (ECM) of skeletal muscle is a very rigid structure
that helps to support the high levels of mechanical stress that is placed on the
muscle tissue. Much like the ECM’s of other cell types, skeletal muscle ECM is
largely comprised of collagen, with collagens I and III being predominant in the
epi-, peri- and endomysium and collagen IV being predominant in the basement
membrane of adult skeletal muscle (Gillies & Lieber, 2011; Light & Champion,
1984). Typical ECM proteins such as proteoglycans, glycoproteins and matrix
remodeling enzymes can also be found in skeletal muscle along with several
types of mononuclear cells. Fibroblasts are the predominant type of mononuclear
cell in the skeletal muscle ECM and are largely responsible for producing the
majority of the ECM components such as fibronectin, collagen and MMP’s
(Archile-Contreras, Mandell, & Purslow, 2010; Gatchalian, Schachner, & Sanes,
1989; Kuhl et al., 1984).
Although fibroblasts are the predominant mononuclear cell in skeletal
muscle, macrophages are typically present in considerable number as well.
Damaged muscle fibers attract monocytes to the site of injury through
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chemotaxis. These monocytes switch to an anti-inflammatory profile before
differentiating into macrophages. Upon phagocytosis of muscle cell debris,
macrophages shift towards an anti-inflammatory profile, which causes them to
release growth factors such as transforming growth factor -β (TGF-β) and basic
fibroblast growth factor (bFGF), resulting in stimulation of muscle satellite cell
migration (Arnold et al., 2007; Robertson, Maley, Grounds, & Papadimitriou,
1993). Tissue injury causes significant increases in macrophage infiltration 2
days post injury and a substantially greater increase after 3 days. However,
these levels begin to subside by day 6 (Pimorady‐Esfahani, Grounds, &
McMenamin, 1997). Research suggests that macrophages are rather crucial for
skeletal muscle growth and repair. Inflammatory macrophages stimulate
myogenic cell proliferation, while anti-inflammatory macrophages stimulate
myogenic cell differentiation into myotubes (Arnold et al., 2007). Complete
removal of macrophages after muscular injury hinders the repair process and
decreases the diameter of regenerating muscle fibers.

Myostatin and Follistatin
Tissue growth and repair is tightly regulated by factors secreted by the
skeletal muscle (myokines) as well. Myostatin, a member of the transforming
growth factor –β (TGF-β) superfamily, is a myokine that is well-known for its
ability to inhibit muscular growth. It has been demonstrated that hindlimb
unloading induced muscular atrophy in mice resulted in elevated myostatin levels
that were apparent after 1 day in the gastrocnemius muscle (Carlson, Booth, &
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Gordon, 1999). Reisz-Porszasz et al. demonstrate that myostatin overexpressing mice exhibit decreased bodyweight, muscle mass, myonuclear
number and muscle fiber cross sectional area in the quadriceps, gastrocnemius
and tibialis anterior muscles when compared to wild type (WT) controls (ReiszPorszasz et al., 2003). Conversely, another study by Whittemore et al.
demonstrates that inhibition of myostatin using an antibody blockade in C57 (WT)
male and BALB/c female mice results in elevated quadriceps and gastrocnemius
weights, increased total bodyweight and lean mass as well as increased grip
strength (Whittemore et al., 2003). Research suggests that myostatin may inhibit
muscle growth through suppression of satellite cell differentiation and myoblast
proliferation (Joulia et al., 2003; Thomas et al., 2000; Wehling, Cai, & Tidball,
2000). Muscle fibers with higher expression of myostatin exhibit lower satellite
cell numbers (Wehling et al., 2000). However, it appears that myostatin inhibits
myoblast proliferation through halting myoblast cell cycle progression in the G0
(resting), G1 and G2 (growth) phases of the cell cycle, preventing myoblasts from
turning into new myocytes (Joulia et al., 2003; Thomas et al., 2000).
While myostatin serves as a direct inhibitor of muscle growth by
preventing differentiation of satellite cells and proliferation of myoblasts, follistatin
(Fst), an autocrine glycoprotein, is a known inhibitor of members of the TGF-β
superfamily, including myostatin. Lee et al. demonstrated that follistatin
overexpressing mice exhibited dramatic increases in muscle mass that rivaled
those of myostatin null mice (Lee & McPherron, 2001). It appears that myostatin
elicits its inhibitory effects through binding of the activin receptor IIB (Act RIIB).
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Follistatin not only directly binds to and inhibits myostatin, but also blocks
myostatin signaling at the Act RIIB. Mice overexpressing a dominant negative
form of the Act RIIB also displayed dramatic increases in weight and muscle
mass. Similarly, Nakatani et al. utilized a mouse model that expresses a follistatin
derived inhibitor (FSII) of myostatin that doesn’t affect activin signaling. FSII
expressing mice exhibited substantial increases in muscle mass and strength
compared to WT mice (Nakatani et al., 2008). When crossbred with mdx mice
(dystrophin knockout mice), which usually display severe muscular atrophy and
weakness, these FSII/mdx mice have elevated strength and mass compared to
mdx mice. In mdx mice, excessive macrophage infiltration into the skeletal
muscle is a major factor that causes adverse skeletal muscle remodeling. The
FSII/mdx mice also display a substantial decline in macrophage number in the
quadriceps femoris compared to mdx mice (Nakatani et al., 2008). Another study
from Lee et al. demonstrated that follistatin heterozygous knockout mice have a
significant reduction in muscle size and a shift towards a more oxidative fiber
type (Lee et al., 2010). These mice have reduced myocyte cross sectional areas,
produce less twitch force and tetanic force and exhibit impaired muscle
remodeling in response to injury.

Pathological Remodeling
During pathological conditions, the structure of skeletal muscle can
become adversely remodeled, causing it to become fibrotic and excessively rigid,
preventing proper function. Skeletal muscle fibrosis is apparent in diabetes,
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immobilization and muscular dystrophy (Alexakis, Partridge, & Bou-Gharios,
2007; Berria et al., 2006; Duance, Stephens, Dunn, Bailey, & Dubowitz, 1980;
Williams & Goldspink, 1984). Fibrotic muscle is characterized by increased
collagen deposition due to elevated activity of fibroblasts, satellite cells,
myofibers and inflammatory cells such as monocytes/macrophages. Following
pathological or chronic tissue injury, myostatin directly stimulates fibroblast
activity via activin receptor IIB, causing fibroblast deposition of fibrinogen and
collagen (McCroskery et al., 2005). Furthermore, activated fibroblasts directly
stimulate inflammatory macrophages through integrin receptor MAC-1, arousing
their production of inflammatory factors such as interleukin 1-β (IL-1β) and tumor
necrosis factor-α (TNF-α) (Vidal et al., 2008). In pathological states related to
chronic inflammation, processes such as these continue, causing skeletal muscle
fibrosis and dysfunction.
It has been well established that mdx mice, a model that represents
muscular dystrophy in humans, display a decrease in skeletal muscle mass,
myocyte cross sectional area and muscular strength, as well as elevated
macrophage infiltration and muscle fibrosis (Bogdanovich et al., 2002; Desguerre
et al., 2012; Gutpell, Hrinivich, & Hoffman, 2015; Nakatani et al., 2008). Gutpell
et al. demonstrate that 8 week old mdx/utrn +/- mice, which lack dystrophin and
utrophin (another crucial protein in skeletal muscle structure), display extensive
fibrosis in the gastrocnemius and diaphragm; while age matched mdx mice only
displayed fibrosis in the diaphragm (Gutpell et al., 2015). Other studies suggest
that myostatin inhibition significantly ameliorates muscular function in mdx mice,
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producing elevated muscle weight, contractile force and cross sectional area, as
well as attenuating macrophage infiltration into the skeletal muscle (Bogdanovich
et al., 2002; Nakatani et al., 2008).

Homocysteine
Homocysteine Metabolism
Homocysteine (Hcy) is a sulfur containing, non-essential amino acid that is
derived from dietary methionine. After absorption from the digestive tract,
methionine is converted into S-adenosylmethionine (SAM) by ATP and
methionine adenosyl triphosphate, leaving it with a transferrable methyl group.
The methyl group is donated for normal cellular methylation requirements and
becomes S-adenosyl-homocysteine (SAH). SAH hydrolase is an enzyme that
reversibly hydrolyzes SAH, which produces homocysteine (Selhub, 1999).
Homocysteine is typically metabolized through two key processes known
as trans-sulfuration and remethylation (See Figure 1). Through the transsulfuration process, homocysteine is irreversibly converted into cystathione via
vitamin B6 dependent enzyme Cystathione Beta Synthase (CBS). Cystathione is
then hydrolyzed by cystathione gamma-lyase into cysteine. This process occurs
in the kidneys, liver, pancreas and the small intestines and allows for
homocysteine molecules to be permanently removed from the body. However,
through the remethylation pathway, homocysteine is remethlyated back into
methionine by methionine synthase (MS), which depends upon folate (vitamin
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B12) as a cofactor. MS uses N-5-methyl tetrahydrofolate (methyl-THF) as a
methyl donor to convert homocysteine into methionine, producing THF. THF is
remethylated through a reaction catalyzed by methyl tetrahydrofolate reductase
(MTHFR) back into methy-THF. This process occurs in most tissues except for
the liver and kidneys, where betaine serves as methyl donor through a reaction
catalyzed by betaine-homocysteine-methyltransferase (BHMT) (Selhub, 1999).

Figure 1. Schematic representing the overview of homocysteine formation and
metabolism.
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Hyperhomocysteinemia
Homocysteine is present in healthy human plasma at a range of 5 to 15µM
(Hillenbrand, Hillenbrand, Liewald, & Zimmermann, 2008).
Hyperhomocysteinemia (HHcy) is a condition where plasma Hcy levels become
>15µM/L. HHcy has been implicated as a potential cause of numerous disease
states such as hypertension, stroke, cardiovascular disease, and skeletal muscle
dysfunction. HHcy is directly correlated with aortic stiffness, decreased renal
function, endothelial dysfunction, and hypertension, with increases in
homocysteine eliciting linear increases in the aforementioned pathologies,
suggesting a causative effect (Bortolotto et al., 1999; Naess et al., 2013; SuttonTyrrell et al., 1997; Wiernicki et al., 2011; Zheng et al., 2013).
Hyperhomocysteinemia occurs when there is impairment in one or more of
the metabolic processes used to remove homocysteine from the body. CBS or
MTHFR mutations, low dietary folate, impaired renal clearance, or a high dietary
intake of methionine are known causes of HHcy (Hayden & Tyagi, 2004; Kanwar
et al., 1976; S. C. Tyagi et al., 2005; Veeranki & Tyagi, 2013). Several of the
mechanisms through which HHcy may cause disease have been discovered.
Hcy increases reactive oxygen species (ROS) production through the formation
of mixed disulfides, protein homocysteinylation, and through auto-oxidation
(Signorello et al., 2007; S. C. Tyagi et al., 2005). Homocysteine has been shown
to cause dephosphorylation and uncoupling of endothelial nitric oxide synthase
(eNOS), leading to a decrease in endothelial NO production (Tyagi et al., 2009).
Decreased nitric oxide attenuates vascular responsiveness to wall shear caused
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by changes in blood flow, preventing proper vaso-relaxation. Moreover, the
increased wall stress associated with less pliable vessels elevates arterial
pressures and decreases perfusion to the surrounding and distal tissues
(Jacobson et al., 2007; Levy et al., 2008). This reduction in perfusion increases
ROS production, starting a vicious cycle of ROS accumulation and tissue
damage.
Signorello et al. demonstrated that type 2 diabetics have increased total
plasma homocysteine levels when compared to control subjects (Signorello et
al., 2007). It was found that the platelets of type 2 diabetic patients had
significantly lower basal NO levels, decreased levels of reduced glutathione (an
intracellular anti-oxidant), and increased ROS production when compared to
those of control subjects. Hcy has also been shown to inactivate peroxisome
proliferator activated receptor – α and – γ (PPAR-α, PPAR-γ), which are proantioxidants that have been shown to promote synthesis of superoxide
dismutase (SOD) and decrease oxidative stress (Mujumdar, Tummalapalli, Aru,
& Tyagi, 2002). This decreased activity of PPAR by Hcy may escalate
constrictive vascular remodeling.

Hyperhomocysteinemia and Skeletal Muscle
Although common muscular disorders, such as muscular dystrophy,
sarcopenia and immobilization, have been extensively researched, there is a not
a lot of data available on the effects of HHcy on skeletal muscle function. Swart
et al. demonstrated that in elderly individuals (mean = 75.6 years of age), plasma
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Hcy levels had a strong inverse correlation with grip strength and functional
capabilities. High Hcy levels resulted in poor grip strength in men and lower
functional ability, with functional abilities including walking, climbing stairs and
rising from a chair (Swart et al., 2013). In cystathione beta synthase deficient
mice (CBS+/-), a model for mild to moderate HHcy, It was demonstrated that 28
days after induction of hind limb ischemia CBS+/- mice displayed blunted hind
limb perfusion and lower collateral blood vessel development when compared to
WT mice (Veeranki, Givvimani, Pushpakumar, & Tyagi, 2014). CBS+/- mice also
demonstrated blunted vascular endothelial growth factor (VEGF), hypoxia
inducible factor (HIF1-α) and peroxisome proliferator activated receptor
coactivator 1-α (PGC1-α) after 28 days of ischemic recovery, when compared to
control. Another study by Veeranki et al. demonstrates that CBS+/- skeletal
muscle is less fatigue resistant, produces less contractile force and has lower
muscle ATP levels compared to C57 wild type mice (S. Veeranki et al., 2015). It
was discovered that CBS+/- skeletal muscle has lower dystrophin and
mitochondrial transcription factor A (mtTFA) when compared to controls (See
Figures 2 and 3 below). Although these studies demonstrate some of the effects
of HHcy on skeletal muscle, more data is needed to determine the mechanism by
which HHcy causes skeletal muscle impairment.
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B

C

Figure 2: Maximal force production is decreased in the soleus and EDL of
CBS +/- mice, possibly due to decreased skeletal muscle ATP generation.
The above data are reproduced from a 2015 article by Veeranki et al., (S.
Veeranki et al., 2015). The above data demonstrate that maximal force
generation is reduced in the A)EDL and B)soleus of CBS +/- mice. This is likely
due to an observed decrease in C) skeletal muscle ATP production.
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B

Figure 3: CBS+/- mice have lower skeletal muscle expression of
Dystrophin, mtTFA and NRF-1; this is reversed with exercise. The above
data are reproduced from a 2015 article by Veeranki et al.,(S. Veeranki et al.,
2015). These data indicate that A) dystrophin, mtTFA and B) nuclear respiratory
factor (NRF-1), a transcriptional regulator of mtTFA, are significantly reduced in
CBS +/- mice compared to C57. Exercise increases mtTFA and NRF-1 levels.
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Matrix Metalloproteinase-9
Matrix Metalloproteinases (MMP’s) are largely responsible for the proper
degradation of the ECM in healthy individuals. MMP’s are zinc and calcium
dependent endoproteinases that are secreted by many cell types such as
macrophages, fibroblasts, vascular smooth muscle cells and myocytes. Matrix
Metalloproteinase-9 (MMP-9) is classified as a gelatinase that has the ability to
degrade components of the extracellular matrix (ECM), including collagen type IV
and elastin (the main elastic component of the arterial wall). MMP-9 is stimulated
through activation of extracellular matrix metalloproteinase inducer (EMMPRIN)
via p38 MAPK stimulation (Huang et al., 2011; Reddy et al., 2010), as well as
through extracellular signal-regulated kinase (ERK)/ nuclear factor-κB (NF-κB)
dependent activator protein (AP-1) activation (Fan, Meng, Wang, Cao, & Wang,
2011; Seung Jin Lee et al., 2012; Moshal et al., 2006; Reddy et al., 2010; Neetu
Tyagi et al., 2009). In healthy muscle tissues, MMP-9 is known for playing a role
in the repair and remodeling of the tissue as well as angiogenesis (Bellafiore et
al., 2013; Chen & Li, 2009; Kherif et al., 1999; Lewis, Tippett, Sinanan, Morgan,
& Hunt, 2000; Mackey, Donnelly, Turpeenniemi-Hujanen, & Roper, 2004;
Zimowska, Brzoska, Swierczynska, Streminska, & Moraczewski, 2008). It has
been localized to cardiomyocytes, around skeletal muscle fibers, capillaries and
within the skeletal muscle ECM (Bellafiore et al., 2013; Rullman et al., 2009).
Research has demonstrated that MMP-9 is crucial for the onset of angiogenesis
(Bellafiore et al., 2013) and for maintaining proper compliance and distensibility
of arteries (Flamant et al., 2007). During growth and repair of skeletal muscle,
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MMP-9 has been shown to stimulate satellite cell migration and differentiation
through degradation of the ECM basement membrane, assisting with their
mobility into the muscle (Chen & Li, 2009; Kherif et al., 1999; Lewis et al., 2000;
Zimowska et al., 2008).

MMP-9 and Disease
Excessive inflammation and oxidative stress can lead to abnormal
activation of MMP-9, causing excessive degradation of the ECM, abnormal
vascular remodeling and endothelial dysfunction, which are associated with
hypertension and arterial stiffness (Onal et al., 2009; Wallace et al., 2005).
Wallace et al. demonstrate that patients with isolated systolic hypertension had
significantly elevated MMP-9 levels and higher pulse wave velocities (PWV, a
measure of arterial stiffness) when compared to age-matched controls (Wallace
et al., 2005). It was determined that MMP-9 levels correlated linearly with PWV,
suggesting that MMP-9 may be, at least in part, a cause of arterial stiffening and
hypertension.
Tyagi et al. demonstrate that mitochondrial induced oxidative stress
activation of MMP-9 leads to degradation of the gap junction protein connexin-43
(Cx-43) in the myocardium (N. Tyagi, Vacek, Givvimani, Sen, & Tyagi, 2010).
Degradation of Cx-43 elicits fibrosis and ventricular dysfunction. Another study
by Onal et al. confirms the finding that MMP-9 levels are higher in individuals with
hypertension and that antihypertensive treatment lowers MMP-9 to control group
levels (Onal et al., 2009). Furthermore, MMP-9 is induced by EMMPRIN in the
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atherosclerotic carotid lesion of advanced atherosclerotic plaque, leading to
abnormal ECM remodeling and atheroma instability (Yoon et al., 2005).

MMP-9 and Skeletal Muscle
Although there has been extensive research on the effects of MMP-9 in
cardiovascular disease and vascular remodeling, the data on the effects of
abnormal MMP-9 expression in skeletal muscle diseases is relatively limited.
With MMP-9 playing a large role in collagen/elastin degradation in the ECM of
skeletal muscle tissues, it would suggest that MMP-9 hyperactivity could create
pathological conditions. In Duchenne’s muscular dystrophy (DMD), which is
characterized by skeletal muscle weakness and atrophy, it was determined that
MMP-9 levels are significantly elevated in serum samples of mdx mice and DMD
patients when compared to their healthy counterparts (Nadarajah et al., 2011).
Similarly, people and animals infected with immunodeficiency viruses suffer from
exacerbated muscle wasting. In rhesus macaques infected with the simian
immunodeficiency virus, chronic binge alcohol administration leads to significant
increases in MMP-9 mRNA expression in skeletal muscle and was associated
with ECM remodeling and fibrosis (Dodd et al., 2014).

MMP-9 and Hyperhomocysteinemia
Hyperhomocysteinemia is a well-known stimulus for MMP-9 activity (Lee
et al., 2012; Moshal et al., 2006; Tyagi et al., 2009) and strongly correlates with
its activity in vascular disease (Wiernicki et al., 2011). Hcy stimulates MMP-9
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production in several cell types including ventricular endothelial cells, brain
endothelial cells and macrophages. Studies suggest that Hcy largely upregulates
MMP-9 expression in these cell lines through an oxidative stress induced
ERK/AP-1 pathway (Lee et al., 2012; Moshal et al., 2006; Tyagi et al., 2009).
Tyagi et al. determined that HHcy also induces MMP-9 activation through ERK,
leading to degradation of the extracellular matrix (Tyagi et al., 2009). It was
shown that homocysteine acts as an antagonist of the gamma aminobutyric acid
–A (GABA-A) receptor, leading to increased ROS production, increased MMP-9
activity, and decreased NO production through the uncoupling of eNOS.
Pharmacological stimulation of the GABA-A receptor attenuates Hcy induction of
MMP-9. The GABA-A receptor controls several antioxidative enzymes, such as
thioredoxin and NADPH oxidase-4, indicating enhanced ROS production acts as
the MMP-9 stimulus. Lee et al. determined that Hcy induction of MMP-9 also
occurs through a separate Akt pathway in murine macrophages (Seung Jin Lee
et al., 2012).

EMMPRIN induction of MMP-9
Extracellular matrix metalloproteinase inducer, or EMMPRIN, is a
membrane bound protein found in most cell types. It is known for mediating
cellular signaling cascades, particularly those stimulating MMP’s (Venkatesan et
al., 2010). Elevated EMMPRIN expression is associated with ROS production
(Siwik et al., 2008) and numerous disease states such as atherosclerosis (Major,
Liang, Lu, Rosebury, & Bocan, 2002), rheumatoid arthritis (Zhu et al., 2005) and
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cancer (Guo, Li, Zucker, & Toole, 2000). Extensive research has demonstrated
that EMMPRIN is a potent inducer of MMP-9 (Fan et al., 2011; Reddy et al.,
2010; Tarin et al., 2011; Yoon et al., 2005). Studies suggest that EMMPRIN is
stimulated by several inflammatory molecules including the inflammatory
cytokines such as interleukin-18 and visfatin as well as cyclophilin A, a potent
ROS inducer (Fan et al., 2011; Reddy et al., 2010; Yuan, Ge, & He, 2010). The
exact pathways for EMMPRIN stimulation are still largely undetermined,
however, it appears that these molecules stimulate EMMPRIN through a cGMP,
p38-ERK 1/2-NF-κB signaling pathway (Fan et al., 2011; Huang et al., 2011;
Tarin et al., 2011). Interestingly, it appears that EMMPRIN utilizes the same
p38/ERK/NF-κB pathway to stimulate other molecules such as MMP-9 (Reddy et
al., 2010; Yuan et al., 2010). EMMPRIN and MMP-9 co-expression are found
prevalently in atherosclerotic plaques/atheromas and ischemia/reperfusion injury
to cardiac tissue (Major et al., 2002; Tarin et al., 2011; Yoon et al., 2005).
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Macrophages
Macrophages are mononuclear white blood cells that are derived from
differentiating monocytes in tissues. They are used both in adaptive and innate
immune responses and are phagocytic by nature, meaning they engulf debris
and pathogens for disposal. Macrophages stimulate the immune system by
signaling other immune cells such as lymphocytes and promote inflammation
through the release of pro-inflammatory cytokines, ROS and NO, which are used
as an attack mechanism against invading pathogens. After phagocytosis of
pathogen, macrophages present the antigen to a corresponding helper T cell,
which then signals for the production of antibodies against the antigen, helping
with the body’s adaptive immunity. Although macrophages are necessary for
adequate immune response, they have been suggested to exacerbate a number
of diseases such as obesity, type II diabetes, atherosclerosis, and cancer (Mills,
2012; Sica & Bronte, 2007; Sica & Mantovani, 2012; Tavakoli & Asmis, 2012).

M1 vs M2 Macrophages
The phenotype and function of macrophages is controlled by
environmental signals. Two polarized phenotypes of macrophages are denoted
as M1 or M2. The M1 phenotype is the destructive, “classically activated”
subset, while the M2 is called the “alternatively activated” subset, associated with
growth and repair (Mills, 2012; Sica & Mantovani, 2012). The M1 phenotype is
stimulated by Interleukin-12 (IL-12), lipopolysaccharide and interferon-γ and can
be identified by high expression of the cell surface marker CD40 (Aron24

Wisnewsky et al., 2009; Munder, Mallo, Eichmann, & Modolell, 1998; Sica &
Mantovani, 2012). M2 macrophages are known to be stimulated by interleukin-10
(IL-10) and interleukin-4 (IL-4) and can be identified by the cell surface markers
CD163 and CD206 (Aron-Wisnewsky et al., 2009; Fiorentino, Zlotnik, Mosmann,
Howard, & O'Garra, 1991; Lang, Patel, Morris, Rutschman, & Murray, 2002; Sica
& Mantovani, 2012).
Macrophages are recruited to a specific area through chemical signaling
known as chemotaxis. When the resulting phenotype of the signaled
macrophage is M1, the macrophage attacks pathogens with a barrage of proinflammatory factors. The M1 macrophages will release pro-inflammatory
cytokines, ROS, and NO through increased production of inducible nitric oxide
synthase (iNOS) (Leibovich et al., 1987; Mills, 2012; Sica & Mantovani, 2012;
Weisser, McLarren, Kuroda, & Sly, 2013). When signaled to damaged
endothelium or areas of arterial damage, the pro-inflammatory action elicited by
M1 macrophages is thought to initiate or progress the damage that causes
vascular pathologies such as atherosclerosis.
Conversely, the M2 phenotype is known to help promote survival and
angiogenesis through the release of anti-inflammatory cytokines and growth
factors. M2 macrophages have been shown to release IL-10, an inhibitor of proinflammatory cytokines, PPAR-γ, which is a pro-antioxidant that improves insulin
sensitivity, and VEGF, which is associated with angiogenesis, as well as other
proliferative factors (Fiorentino et al., 1991; Lang et al., 2002; Mills, 2012;
Odegaard et al., 2007; Sica & Mantovani, 2012; Zeyda et al., 2007).
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M1 and M2 Macrophages in Injury and Disease
Kigerl et al. were able to demonstrate the difference between the M1 and
M2 phenotype in an injured mouse spinal cord (Kigerl et al., 2009). Their data
suggest that M1 macrophages rapidly respond at sites of spinal cord damage
and produce a neurotoxic effect, which profoundly overpowers the M2 response.
In contrast, it is shown that induction of the M2 phenotype in these macrophages
actually elicits axonal growth for neural regeneration.
Obesity displays a low level of chronic inflammation that is thought to be
associated with the development of associated diseases, such as insulin
resistance. Aron-Wisnewsky et al. demonstrate that M1 macrophages are
significantly increased in the adipose tissue of obese women (Aron-Wisnewsky et
al., 2009). After 3 months of gastric bypass surgery, it was found that the ratio of
M1/M2 macrophages was 2-fold lower than pre-surgery, suggesting a switch to a
less inflammatory profile.
El Hadri et al. found that when stimulated with thioredoxin-1, an antiinflammatory protein, macrophages are shifted to an M2 phenotype and this
switch antagonizes atherosclerosis (El Hadri et al., 2012). In contrast, despite the
proliferative, anti-inflammatory nature of M2 macrophages, it has been
discovered that M2 macrophages may also be associated with increased
atherogenesis. Oh et al. demonstrated that M2 macrophages are responsible for
foam cell formation and deposition into the intima of the vascular wall, promoting
arterial plaque formation (Oh et al., 2012). IL-4 and IL-10 stimulation of
macrophages promoted ER stress that generated PPAR-γ and JNK activation,
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leading to an M2 phenotype. When the M2 macrophages were exposed to
oxidized low density lipoprotein, foam cell formation occurred because of CD36
and scavenger receptor-A1 (SR-A1) induction. This transformation of M2
macrophages into foam cells could play a major role in the formation and
progression of atherosclerotic plaque.

Macrophages and Hyperhomocysteinemia
Interestingly, homocysteine shares a causative link with the atherogenic
actions of M1 and M2 macrophages. Research suggests that that HHcy induces
VEGF and monocyte chemoattractant protein-1 (MCP-1, a potent chemotactic
agent), expression via an NF-κB dependent pathway in THP-1 human
macrophages, which are both associated with vascular disease progression
(Wang et al., 2001). This study demonstrates HHcy stimulates macrophage
migration into the arterial intima through a 4.8 fold induction of MCP-1. Other
studies also demonstrate that Hcy upregulates VEGF production in macrophages
via NF-κB activation (Kiriakidis et al., 2003; Maeda, Yamamoto, Fujio, & Azuma,
2003). More recently, a study by Lee et al. suggested that Hcy treatment resulted
in elevated MMP-9 production in the J774A.1 murine macrophage cell line (Lee
et al., 2012). 12 hours of 300µM Hcy treatment resulted in significantly elevated
MMP-9 protein expression and activity. Further analysis revealed that this
induction occurred through ERK and Akt pathways.
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Macrophages in Skeletal Muscle
Macrophages are typically present in substantial quantity in the skeletal
muscle, largely in the epimysium and perimysium (Chazaud et al., 2009). One
major role of macrophages in the skeletal muscle is to assist with tissue growth
and repair. Damaged muscle fibers attract monocytes to the site of injury
through chemotaxis, where the monocytes differentiate into macrophages. Upon
phagocytosis of muscle cell debris, macrophages shift towards an antiinflammatory profile, which causes them to release growth factors such as TGF-β
and basic fibroblast growth factor (bFGF), resulting in stimulation of muscle
satellite cell migration (Arnold et al., 2007; Robertson et al., 1993). The
macrophage shift towards an anti-inflammatory or M2 profile seems to occur
between 1 to 3 days post injury (Chazaud et al., 2009). Tissue injury causes
significant increases in macrophage infiltration 2 days post injury and a
substantially greater increase after 3 days. However, these levels begin to
subside by day 6 (Pimorady‐Esfahani et al., 1997).
Research suggests that macrophages are rather crucial for skeletal
muscle growth and repair. If monocyte recruitment to the site of damaged
skeletal muscle is interrupted within the first 24 hours post-injury, the repair
process is completely attenuated. Inflammatory macrophages stimulate
myogenic cell proliferation, while anti-inflammatory macrophages stimulate
myogenic cell differentiation into myotubes (Arnold et al., 2007). Complete
removal of macrophages after muscular injury also hinders the repair process
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and decreases the diameter of regenerating muscle fibers (Arnold et al., 2007;
Chazaud et al., 2009).
As discussed earlier, during pathological conditions, macrophage
infiltration into the skeletal muscle can be heavily increased and promote a
potent inflammatory profile. This chronic state of inflammation elicits adverse
muscle remodeling through tissue fibrosis and muscular atrophy.

Exercise Training
It has been well established that regular exercise is associated with
improvements in overall physical fitness, maintenance of health, a decreased risk
of many disease states, and more recently, alleviation of many disease
pathologies (Fiuza-Luces, Garatachea, Berger, & Lucia, 2013). Despite this
common knowledge, technological advancements associated with modern day
living have caused dramatic increases in sedentary lifestyle. Approximately 43%
of American adults and 31% of adults worldwide are considered to be physically
inactive (Hallal et al., 2012). This lack of physical exercise has been associated
with elevated cardiovascular disease mortality risk and is estimated to be
attributable for 16% of all-cause death (Blair, 2009). Furthermore, decreased
physical activity has also been associated with the development of hypertension
and obesity (Tremblay, Esliger, Copeland, Barnes, & Bassett, 2008), which are
known to cause a wide variety of other disease states.
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Supporting the health promoting advantages of regular exercise, a review
by Fiuza-Luces et al. suggests that regular exercise has physiological health
benefits that are equivalent to a multi-drug (blood thinner, anti-diabetic, antihypertensive, anti-lipid/cholesterolemic) regimen (Fiuza-Luces et al., 2013).
When compared to the benefits of this multiple drug treatment program, exercise
is as capable, if not more proficient, at improving lipid profile, blood pressure,
diabetes prevention, and reduction of cardiovascular events. Most of these
benefits are derived from chemicals released by contracting skeletal muscle
(myokines), such as IL-6, which increases the production of anti-inflammatory
cytokines, angiogenic factors, and follistatin, which improves muscle growth and
possibly insulin sensitivity through inhibition of myostatin (Pedersen, Akerstrom,
Nielsen, & Fischer, 2007).
Acute exercise has been shown to elevate NO production through a 37%
increase in nitric oxide synthase (NOS) in rat gastrocnemius muscle (Roberts,
Barnard, Jasman, & Balon, 1999). Through adaptation, regular exercise
improves endothelial function, at least in part, due to elevated endothelial nitric
oxide synthase (eNOS) mRNA expression, allowing for enhanced NO production
and vasoreactivity (Fogarty et al., 2004; Griffin, Woodman, Price, Laughlin, &
Parker, 2001; Hambrecht et al., 2000). Improved stem cell production and
release also contributes to the benefits derived from exercise (Macaluso &
Myburgh, 2012). Endothelial progenitor cells stimulated by exercise have been
shown to migrate to the damaged endothelium to initiate repair or angiogenesis,
improving vascular function (Crosby et al., 2000; Moreno, Sanz, & Fuster, 2009).
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It has also been revealed that exercise improves cellular responsiveness to
stress through improved metabolic efficiency and elevated anti-oxidative
capacity, resulting in decreased free radicals and mitigation of ROS induced
pathologies (Gomez-Cabrera et al., 2005; Jackson, 2005; Khassaf et al., 2001;
McArdle, Pattwell, Vasilaki, Griffiths, & Jackson, 2001; Radak, Chung, & Goto,
2008).

Exercise and Homocysteine
It has been demonstrated that exercise is capable of lowering Hcy levels,
suggesting that exercise can potentially negate the adverse effects of HHcy on
different organs (Hrncic et al., 2013; König et al., 2003; Neuman et al., 2013;
Randeva et al., 2002; Vincent et al., 2006). Neuman et al. stated that exercise
was capable of preventing increases in plasma Hcy concentration that were
produced by 7 weeks of a folate restricted diet in mouse models (Neuman et al.,
2013). The low folate diet group that was not exercised displayed significant
increases in Hcy levels when compared to non-exercise controls and controls
receiving exercise. It was demonstrated that this prevention of
hyperhomocysteinemia was associated with a 2 fold increase in renal betainehomocysteine S-methyltransferase (BHMT) activity. BHMT is a folate
independent methyltransferase that remethylates Hcy into methionine by utilizing
a methyl group from betaine. Another study revealed the ability of exercise to
prevent increases in lipid peroxidation and decreases in superoxide dismutase
and catalase activity by Hcy in mice (Hrncic et al., 2013). Human studies have
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also discovered that exercise lowers Hcy levels in overweight and obese adults
as well as in women with polycystic ovarian syndrome (Randeva et al., 2002;
Vincent et al., 2006).

Exercise and MMP-9
Despite an abundance of research on MMP-9 and its association with
vascular complications, the effects of regular exercise on MMP-9 are rather
unclear. After single acute bouts of exercise, it is shown that MMP-9 activity is
elevated around the capillaries and cardiomyocytes (Bellafiore et al., 2013;
Rullman et al., 2009). Increased serum levels of MMP-9 have been reported after
8 days of a single exercise bout and MMP-9 remains elevated even after 15 days
of training (Bellafiore et al., 2013; Mackey et al., 2004; Rullman et al., 2009). This
could suggest that MMP-9 is being utilized to help promote exercise induced
angiogenesis. Interestingly, although MMP-9 activity is increased after a single
exercise bout, it has been revealed that there is no change in enzyme activity
after extended training regimens, therefore, it is possible that MMP-9 activity may
only be utilized in the initial phases of new capillary growth (Rullman et al., 2009).

Exercise and Macrophages
It is known that acute bouts of exercise stimulate the phagocytic activity of
macrophages (De la Fuente, Martin, & Ortega, 1990; Ferrandez & De la Fuente,
1999). This makes sense since macrophages play a crucial role in phagocytosis
of muscle debris and the muscular repair process. Regular exercise appears to
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increase phagocytic activity of macrophages as well, which is more exaggerated
in the elderly, whom typically have a blunted macrophage response to pathogens
(Ferrandez & De la Fuente, 1999). This could be an important mechanism
through which exercise improves immune responsiveness. Although the effect of
exercise on macrophage activity has been well researched, there seems to be
little information available regarding the effects of regular exercise on M1 vs M2
macrophage phenotype differentiation. One study suggests that mice being fed a
high fat diet display a greater ratio of adipose tissue M1/M2 macrophages
compared to normal diet controls (Kawanishi, Yano, Yokogawa, & Suzuki, 2010).
After 16 weeks of exercise training, not only was the increased ratio of M1/M2
macrophages attenuated in the high fat diet group, but the expression level of M2
macrophages was markedly increased. This was accompanied by a decrease in
inflammatory cytokines. Since this is the only study involving exercise and M1/M2
macrophages, it is clear that more research is needed regarding M1 vs M2
macrophage modification by exercise.
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CHAPTER III
HYPOTHESIS AND SPECIFIC AIMS

Key Objective
The objective of this study was to determine the effects of
hyperhomocysteinemia on skeletal muscle dysfunction and investigate if exercise
can attenuate these effects.

Hypothesis
Hyperhomocysteinemia promotes adverse remodeling of skeletal muscle
through induction of inflammatory mechanisms and exercise will mitigate this
inflammatory state (See Figure 4).

Specific Aims
Specific Aim 1: To investigate if HHcy impairs skeletal muscle perfusion and
function and determine if exercise mitigates this effect.
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Specific Aim 2: To investigate changes to the inflammatory state of the skeletal
muscle due to HHcy and determine if exercise can reverse this effect.
Specific aims 1 and 2 will be discussed in Chapter IV.

Specific Aim 3: To investigate changes in macrophage phenotype and skeletal
muscle infiltration due to HHcy and determine if exercise can mitigate this effect.
Specific aim 3 will be discussed in Chapter V.
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Figure 4: Schematic Representation of Overall Hypothesis
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CHAPTER IV
SKELETAL MUSCLE DYSFUNCTION DUE TO HYPERHOMOCYSTEINEMIA

Introduction
Hyperhomocysteinemia (HHcy), having plasma homocysteine levels
>15µM, is a significant risk factor associated with hypertension, atherosclerosis,
abdominal aortic aneurysms and diabetes (Bortolotto et al., 1999; Signorello et
al., 2007; Sutton-Tyrrell et al., 1997; Wiernicki et al., 2011; Zheng et al., 2013).
HHcy can develop due to high dietary methionine, insufficient dietary folate, or
genetic defects in enzymes that metabolize homocysteine, such as cystathione
beta synthase or methyl-tetrahydrofolate reductase. People and animals with
HHcy display pathological imflammation and remodeling of their cardiac and
vascular smooth muscle (Bortolotto et al., 1999; Mujumdar et al., 2002; Shai et
al., 2004; Signorello et al., 2007; Zheng et al., 2013). Muscular remodeling
involves degradation and regeneration of fibrous extracellular matrix (ECM)
proteins such as collagen, elastin and fibronectin. Pathological remodeling can
occur during states of chronic inflammation and is characterized by excessive
collagen deposition and depletion of elastin, causing the muscle to become
fibrotic, unstable and rigid (Gillies and Lieber, 2011).
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Homocysteine is known to induce several inflammatory factors such as
reactive oxygen species (ROS), matrix metalloproteinase-9 and stimulation of
macrophage migration through chemotaxis (Lee et al., 2012; Tyagi et al., 2009;
Wang et al., 2001). MMP-9 is an endoproteinase that degrades collagen within
the ECM. Its ability to degrade the extracellular matrix has been implicated in
cardiovascular remodeling (Spinale et al., 2000; Tyagi et al., 2010). It is strongly
associated with heart failure, hypertension and arterial stiffness and positively
correlates with Hcy levels (Onal et al., 2009; Spinale et al., 2000; Wiernicki et al.,
2011; Yasmin et al., 2005). Macrophages are required for the growth and repair
of damaged muscle tissue, but chronic inflammation can cause macrophages to
become hyperactive and destructive, leading to fibrosis of tissue. Hcy has been
shown to stimulate macrophage migration, indicating that HHcy could promote
remodeling through macrophage activation as well (Wang et al., 2001).
Limb immobilization, diabetes and muscular dystrophy all display
pathological remodeling through excessive fibrosis of the skeletal muscle
(Alexakis et al., 2007; Berria et al., 2006; Duance et al., 1980; Williams &
Goldspink, 1984). Macrophages and MMP-9 are both present in the skeletal
muscle for normal growth and repair, but the inflammation induced by HHcy may
cause adverse skeletal muscle remodeling through amelioration of their activity.
Skeletal muscle is a very metabolically active tissue and therefore requires a rich
blood supply for proper perfusion and function (Holloszy & Coyle, 1984; Saltin,
Radegran, Koskolou, & Roach, 1998). A lack of perfusion reduces clearance of
metabolic oxidative byproducts, which would lead to inflammation. With HHcy
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impairing blood flow through vascular dysfunction, it is very plausible that HHcy
could promote or exacerbate pathological remodeling of skeletal muscle as well.
Individuals with HHcy produce lower maximal grip strength and impaired
functional capabilities when compared to healthy counterparts (Swart et al.,
2013). In CBS+/- mice, a model for HHcy, it is demonstrated that HHcy impairs
hindlimb reperfusion angiogenesis after ischemia caused by femoral artery
ligation (Veeranki et al., 2014). Another study from Veeranki et al. demonstrates
that the skeletal muscle of CBS+/- mice is more fatigable and produces less
contractile force than wild type mice. It was determined that the skeletal muscle
has blunted ATP production, which may be the cause of the fatigability (Veeranki
et al., 2015). The CBS+/- muscle also has decreased dystrophin and
mitochondria transcription factor A (mtTFA) protein expression compared to wild
type, indicating that the muscle is less functional and has lower mitochondrial
activity. There was also an accompanied increase in mir-31 and mir-494, which
respectively inhibit dystrophin and mtTFA. Additionally, there was a significant
decrease in nuclear respiratory factor-1 (NRF-1) expression, which is a
transcriptional promoter of mtTFA. A 4 week swimming protocol was
administered to see if these effects could be attenuated. With the exception of
dystrophin, all of the molecular changes observed in CBS+/- were reversed with
exercise. With HHcy clearly causing functional and molecular changes to skeletal
muscle, we decided to further investigate what changes HHcy is inducing in the
skeletal muscle tissue. It is our hypothesis that HHcy impairs perfusion and
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promotes pathological remodeling in skeletal muscle by inducing chronic
inflammation. We believe that exercise will mitigate these effects.

Methods
Animals and Animal Care
C57BL/6J (WT), CBS+/-(B6129P2), FVB (FVB/NJ) and MMP-9-/(FVB.Cg-Mmp9tm1Tvu/J) were obtained from Jackson Laboratories. CBS+/- mice
are heterozygous knockout mice that display HHcy and are based on the C57
WT model. MMP-9 -/- mice are based on the FVB (WT) model and are
homozygous knockouts for MMP-9. CBS/MMP-9 double KO mice were bred in
our animal facilities through mating of MMP-9-/- and CBS+/- mice. Only
CBS/MMP-9 mice that were genotyped as being heterozygous knockouts for
CBS and MMP-9 homozygous knockouts were used for this study. Animals were
kept in our laboratories animal facility which exposes them to 12 hour of light and
12 hours of dark daily. They were fed normal chow and had free access to a
fresh water supply. For the purpose of harvesting tissues, animals were fully
anesthetized using tri-bromoethanol and euthanized via exsanguination. These
methodologies are both considered humane and appropriate procedures by the
University’s IACUC. Gastrocnemius muscles were harvested for analysis and
snap frozen in liquid nitrogen for western blotting and PCR analysis or
cryopreserved in Peel-A-Way disposable tissue molds (Polysciences,
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Warrington, PA) containing tissue freezing medium (Triangle Biomedical
Sciences; Durham, NC) by freezing in liquid nitrogen for cryo-sectioning.

Exercise Protocol
All 5 mouse breeds had a control group that received no exercise training
for 6 weeks and a group that was exercised on a 6 lane treadmill (Columbus
Instruments; Columbus, OH) for 6 weeks. The treadmill protocol was personally
designed while following mouse exercise guidelines as outlined in the “Resource
Book for the Design of Animal Exercise Protocols,” which was published by the
American Physiological Society in February of 2006 (Kregel et al., 2006). Prior to
the start of exercise, mice were placed in the lanes of the treadmill daily for 5
days for 20 minutes per day with no belt movement to allow them to acclimate to
the environment. Mice were exercised 5 days per week for 6 weeks with
increasing intensity each day. The first two weeks were low intensity to allow for
proper acclimation to a moving belt on the treadmill. The protocol consisted of a
standard training phase for 20 minutes followed by a high-intensity sprint phase
to induce muscular hypertrophy. Before the start of the study, it was determined
that most mouse models had a very difficult time running at speeds greater than
20 m/min for more than a very short duration. To ensure that the protocol finished
at a high intensity, a final training speed of 17 m/min (85% max speed at
baseline) with a final sprint phase speed of 20 m/min (100% of max speed at
baseline) were utilized. On the first day of exercise training, the mice began the
training phase at 5 m/min for 20 minutes (or 100 m in 20 min) and a 15 m/min
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sprint speed for 10 meters. The training phase increased by 0.5 m/min every day
for the duration of the protocol until it reached 17 m/min for 20 minutes (or 340
meters in 20 min) during the final week, where the speed was held constant for
the final 5 training sessions. The sprint phase distance at 15 m/min increased by
5 meters every training session until the half way point where a combination of
15 m/min and 20 m/min training speeds were utilized for 11 training sessions,
followed by 10 training sessions at 20 m/min for increased distance. See figure 5
and table 1 below for clarification.

Figure 5. Line graph representation of the exercise protocol. Red indicates
the distance run in 20 minutes for the standard training part of the protocol.
Green represents the distance run at 15 m/min for the sprint phase, while blue
represents the distance run at 20 m/min.
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Day of
Training
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

Speed For 20
Mins (m/min)

Distance at
15 m/min

5
5.5
6
6.5
7
7.5
8
8.5
9
9.5
10
10.5
11
11.5
12
12.5
13
13.5
14
14.5
15
15.5
16
16.5
17
17
17
17
17
17

10
15
20
25
30
35
40
45
50
50
50
50
50
50
50
50
50
50
50
50
0
0
0
0
0
0
0
0
0
0

Table 1. Table layout of the exercise protocol.

43

Distance at
20 m/min
0
0
0
0
0
0
0
0
0
5
10
15
20
25
30
35
40
45
50
50
80
85
90
95
100
100
100
100
100
100

Blood Pressure Measurments
Blood pressure data was collected before the start of exercise (or control)
and again two days following the completion of exercise training (or 6 weeks of
control). Measurements were taken using a common, non-invasive tail cuff
system (CODA; Kent Scientific: Torrington, CT). Animals were physically
restrained using polymer harnesses designed for use with this system. The
animals were placed on a warming platform for 10 minutes at 37°C to allow them
to acclimate. Mean blood pressure measurements were recorded and used for
this study.

Antibodies and reagents
Antibodies for homocysteine, myostatin and MMP-9 were purchased from
Abcam (Cambridge, MA), while antibodies for VEGF, IL-1β, PPAR-γ, EMMPRIN,
iNOS and all secondary antibodies were purchased from Santa Cruz
Biotechnologies (Santa Cruz, CA). The (glyceraldehyde 3-phosphate
dehydrogenase) GAPDH antibody was purchased from EMD Millipore (Billerica,
MA). All PCR primers were purchased from Invitrogen (Carlsbad, CA).

Plasma Homocysteine Measurement
To measure the differences in levels of homocysteine and
homocysteinylated proteins between groups, blood samples were collected
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through the vena cava of anesthetized animals. Sodium citrate was used to coat
the interior of the syringe prior to blood collection to prevent coagulation. Blood
samples were centrifuged at 6000Xg for 10 minutes and plasma (supernatant)
was carefully pipetted into another tube. Plasma samples were stored at -80°C
until needed. A dot blot was utilized to measure differences in plasma Hcy
levels. Equal volumes of plasma from each sample were blotted onto a
nitrocellulose membrane and allowed to dry for 1 hour. The membrane was
placed in a 3% BSA/0.1% Tween 20 solution diluted in tris-buffered saline (TBS)
at room temperature for 1 hour. Anti-Homocysteine rabbit polyclonal antibody
was diluted 1:5000 in TBST solution and added to membrane for incubation
overnight at 4°C. The membrane was then washed with TBST 3 times for 5
minutes per wash on a rocker at room temperature. Anti-rabbit secondary
antibody was diluted 1:10,000 in TBST and added to membrane for 1 hour at
room temperature. The dot blot was then imaged and developed using
chemiluminescent substrate and analyzed using BioRad ImageLab software
(Hercules, CA).

Laser Doppler Imaging
To measure the blood perfusion of the femoral artery, after receiving
anesthesia, the mice were secured in the supine position and the femoral artery
of the left hind limb was surgically exposed. Femoral artery perfusion was
measured using a laser Doppler imager (MoorLDI; Moor Instruments: Devon,
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UK) for a period of 2 minutes. The mean perfusion over the 2 minute period was
calculated and used for analysis.

Ultrasonography
Ultrasonography was performed before the start of exercise (or control)
and the day following completion of exercise training (or 6 weeks of control).
While under isofluorane anesthesia, mice were placed on a warming platform at
37°C and a commercial hair removal chemical was used to remove all fur from
the hind limb. Imaging of the femoral artery was performed using a Vevo 2100
ultrasound Doppler (Visual Sonics, Toronto, ON, Canada). The femoral artery
was imaged using a MS550D (22-55 mHz) transducer. The B-Mode imaging
program was used to obtain clear cross sectional images of the femoral artery
were obtained to measure the lumen diameter and wall to lumen ratio.

Cryosectioning
Cryopreserved tissues were stored at -80°C until use. Sections of 8 µM
thickness were made using a Cryocut tissue sectioner (Leica CM 1850). Cryosections were placed on poly-L-lysine coated microscope slides, air dried and
stored at -80°C until further use.
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Collagen Staining
A Masson’s trichrome staining kit (Richard Allan Scientific; Kalamazoo,
MI) was used to detect collagen deposition in the gastrocnemius muscle. Cryosections were stained following the manufacturer’s instructions. Collagen
deposition is displayed as a blue color. All images were captured with an
Olympus FluoView 1000 light microscope (B&B Microscope Ltd.; Pittsburgh, PA).
Measurement of collagen content was performed using Image J software (NIH
free software download).

Reverse Transcription Polymerase Chain Reaction (PCR)
Total RNA was isolated from mouse gastrocnemius tissue using Trizol
reagent (Invitrogen; Carlsbad, CA). Purified RNA (1µg) was reverse transcribed
using the Bio Rad iScript Reverse Transcription system (Hercules, CA) according
to the manufacturer’s instruction. To amplify specific gene sequences, primers
were designed and obtained from Invitrogen (Carlsbad, CA). PCR amplification
was performed for 35 amplification cycles in a Biorad DNA Engine Thermo-cycler
(Hercules, CA). PCR products were resolved by gel electrophoresis in 1%
agarose gels. PCR band images were recorded and analyzed using Imagelab
software (Bio-Rad, Hercules, CA). The band intensities of the PCR product were
normalized to GAPDH.
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Real-Time PCR or qPCR
Reverse transcription of RNA occurs in the same manner as described for
Reverse Transcriptase PCR. cDNA product, primers, nuclease free water and
SYBR Green reaction mix (Qiagen; Gaithersburg, MD) were added to wells on a
96 well plate and the gene sequences were amplified for 55 cycles using a
Roche Light Cycler.

Western Blotting
Gastrocnemius tissues were homogenized and lysed in
radioimmunoprecipitation assay (RIPA) lysis buffer, supplemented with a
protease inhibitor cocktail, phenylmethanesulfonylfluoride (PMSF) and sodium
orthovanadate. Lysates were then sonicated for 5 seconds each and then
centrifuged at 8,000 RPM for 10 minutes. Precipitates (protein) were then
transferred to a new tube. Protein concentrations were determined via Bradford
protein estimation assay to ensure equal protein loading, then samples were run
on an SDS poly-acrylamide gel in Tris-glycine SDS buffer for proper protein
separation and were then transferred electrophoretically onto a PVDF membrane
overnight at 4 degrees. The membrane was blocked in a 5% milk TBST solution
for 1 hour. All primary antibodies were diluted at a concentration of 1:1000 in
TBST and membranes were incubated with primary antibody solution overnight
at 4 degrees. After primary incubation, the membranes were washed three times
with TBST solution then incubated with a secondary HRP conjugated antibody
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solution for 1 hour at room temperature. Membranes were then washed three
more times with TBST then developed using a chemiluminescent substrate in a
BioRad Chemidoc (Hercules, CA). Band intensity was determined using BioRad
ImageLab software. All proteins of interest were normalized to the values of
glyceraldehyde 3-phosphate dehydrogenase (GAPDH).

Statistical Analysis
Statistical analysis was performed using both Microsoft Excel and Primer
of Biostatistics software. The Primer of Biostatistics software was used to
perform a one way ANOVA followed by multiple comparisons analysis with
Bonferroni correction. This analysis was performed on the laser Doppler
perfusion, mean blood pressure and % collagen measurements to determine
differences between the means of many groups. Microsoft Excel was used to
perform a standard t-test to determine mean differences for all other assays. An
alpha level of p< 0.05 was used to determine statistical significance. All values
are presented as mean + standard error of the mean.
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Results
Plasma Homocysteine Levels
Using an anti-homocysteine antibody to detect total plasma homocysteine
and homocysteinylated proteins on a dot blot, it was determined that control
CBS+/- mice have a 42% greater plasma homocysteine concentration than
control C57 mice and exercise intervention decreased Hcy levels down to control
C57 levels. Exercised C57 mice also demonstrated a significant decline in
plasma Hcy levels (Figure 6).

Body Mass
At baseline, CBS+/- have significantly reduced body weight when
compared to C57 and all other mouse models (23.7 vs 27.3 g, respectively).
CBS/MMP-9 double KO mice are normal bodyweight and not significantly
different from any group except for CBS+/- mice. After exercise, CBS+/- mice
gained a significant amount of body weight, but no change was observed in any
other group. After exercise, CBS+/- mice were no longer significantly
underweight compared to any other group except for post-exercise MMP-9. In
CBS+/- mice, the weight of the tibialis anterior (TA) was significantly lower than
what was observed in the C57 mice. Although exercise did not significantly
increase the weight of the TA in the CBS+/- mice when compared to the preexercise weight, it was no longer significantly lower than the weight of C57 pre or
post exercise TA muscles (Figure 7).
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Blood Pressure Measurements
CBS+/- mice exhibit significantly higher mean blood pressures than C57
mice and all other groups (122.0 vs 83.8 mmHg respectively) at baseline. After 6
weeks, control CBS+/- did not see a significant change in blood pressure due to
age, but it was still significantly higher than all other groups. However, with 6
weeks of exercise, mean blood pressure in CBS+/- mice significantly decreased
when compared to pre-exercise conditions (122.0 vs 87.1 mmHg respectively),
as well as CBS+/- control conditions and was no longer significantly different
from any other group. CBS/MMP-9 mice are normotensive and did not display
significant differences between any other groups except CBS+/- (Figure 8).

Hindlimb Perfusion
Perfusion of the femoral artery was significantly lower in CBS+/- control
mice than every other control group. Perfusion of the femoral artery in
CBS/MMP-9 mice was not different from any other group except CBS+/-. With
exercise training, the perfusion was significantly increased from baseline in every
group except for CBS/MMP-9, which showed no change. After exercise,
perfusion in CBS+/- mice was not significantly different from any other postexercise group, indicating that perfusion of the hind limb was corrected with
exercise (Figure 9).
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Wall to Lumen Ratio and Lumen Diameter
The wall to lumen ratio, which is inversely correlated to cardiovascular
health, was significantly elevated in CBS+/- mice when compared to every other
group at baseline. With exercise intervention, the wall to lumen ratio in CBS+/mice was significantly reduced when compared to baseline (0.36 vs 0.45,
respectively), indicating that exercise is causing beneficial remodeling of the
vascular smooth muscle. However, it was still significantly higher than C57 mice
at baseline and post-exercise (0.27, 0.24 respectively). No other group saw a
significant change in wall to lumen ratio with exercise. CBS/MMP-9 mice were
not significantly different from any other group at baseline, indicating that MMP-9
may be responsible for the observed remodeling in HHcy. The lumen diameter
of the femoral artery was also significantly declined in CBS+/- mice when
compared to C57 mice at baseline (0.204 mm vs 0.264 mm, respectively), but
was significantly increased by exercise (0.242 mm). Post-exercise lumen
diameter in CBS+/- mice was not significantly different from C57 pre or post
exercise Figure 10).

Collagen Staining
To determine if the impairments in hindlimb perfusion translated to
increased fibrosis of the hindlimb skeletal muscle, collagen staining was
performed on mouse gastrocnemius sections. Indeed, control CBS+/gastrocnemius tissues displayed significantly higher collagen content than
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observed in every other group (14.0% collagen content vs 2.4% in C57 controls).
After exercise intervention, CBS+/- collagen content significantly fell to 2.8%,
making it insignificant from C57 controls or C57+exercise. FVB, MMP-9 and
CBS/MMP-9 control groups were all slightly, but significantly higher than C57
controls. MMP-9 mice saw a decline in muscle collagen content with exercise
training, but, besides CBS+/-, the other groups did not. Although CBS/MMP-9
control mice had significantly higher collagen content in their gastrocnemius than
C57 at controls, they were not different from FVB and MMP-9 controls (Figure
11).

CBS +/- Mice Have Impaired Metabolic Activity in the Skeletal Muscle
Cytochrome C oxidase is the last enzyme in the electron transport chain
and is crucial for oxidative metabolism. Using PCR, it was determined that
control CBS+/- mice display 20% lower cytochrome C oxidase mRNA in the
gastrocnemius muscle when compared to C57 controls, indicating lower skeletal
muscle metabolic activity in CBS+/- mice. However, with exercise training, mRNA
levels were significantly increased to the same levels as expressed in C57. There
was no change observed in C57 with exercise (Figure 12).

Hyperhomocysteinemia Induces Myostatin
Western blotting analysis of the gastrocnemius tissue demonstrated that
control CBS+/- mice have a 2 fold increase in myostatin levels when compared to
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C57 controls, indicating that CBS+/- mice have impaired muscle growth
compared to their wild type counterparts. Although myostatin demonstrated a
general decline with exercise in CBS+/- mice, it was not quite significant (p =
0.055). Surprisingly, C57 mice demonstrated a significant increase in myostatin
levels with exercise when compared to the control group. However, post-exercise
myostatin levels in C57 and CBS+/- tissues were almost identical (1.35 vs 1.39
fold increase from C57 controls respectively), with no significant differences
between the two values. CBS/MMP-9 control levels were not significantly
different from C57 controls (Figure 13).

Exercise Increases Follistatin mRNA Expression
PCR analysis of the gastrocnemius tissues indicated that exercise
significantly increased follistatin mRNA expression in C57 and CBS+/- muscle by
2.5 and 3 fold respectively, when compared to their non-exercise counterparts.
However, although control CBS+/- mice displayed a trend for lower follistatin
expression compared to C57 controls, the value was not significantly less
(p=0.08). Values for CBS+/- mice with exercise were significantly higher than
control C57 values, but not significantly different from C57 with exercise (Figure
13).
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Hyperhomocysteinemia Induces Markers of Hypoxia
Western blotting revealed that control CBS+/- mice express significant
increases in VEGF and iNOS protein when compared to C57 controls (1.32 and
1.44 fold increase, recpectively). As expected, exercise increased both VEGF
and iNOS in C57 mice compared to their control counterparts (1.20 and 1.38 fold
increase, respectively). In exercised CBS+/- mice, VEGF was significantly
reduced while iNOS did not change when compared to CBS+/- controls, with
VEGF being reduced to C57 control levels. VEGF in CBS+/- exercise mice was
also significantly lower than C57 exercise mice. CBS+/- exercise mice expressed
greater iNOS than C57 controls as well, but it was not significantly different from
exercised C57 (Figure 14).

Hyperhomocysteinemia Induces EMMPRIN and MMP-9
EMMPRIN protein, a known inducer of MMP’s, was upregulated in CBS+/control gastrocnemius muscle compared to C57 controls (1.53 fold increase).
Exercise significantly reduced CBS+/-exercise EMMPRIN levels, while increasing
C57 exercise levels compared to their non-exercise counterparts (1.30 and 1.37
fold increase over C57 controls, respectively). CBS+/- and C57 exercise groups
were not significantly different from one another. Not surprisingly, MMP-9 mRNA
expression was significantly higher in CBS+/- controls compared to C57 controls
(0.171 vs 0.047 respectively) and was significantly reduced with exercise (0.030).
However, there were no significant differences between the control and exercise
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C57 groups or CBS+/- exercise. Interestingly, despite the difference in mRNA
expression, MMP-9 protein expression followed a very similar pattern to
EMMPRIN protein expression. MMP-9 was significantly higher (almost 2 fold) in
CBS+/- controls than C57 controls and was significantly reduced with exercise.
Exercise increased MMP-9 levels in the C57 exercise group and there was no
significant difference between this group and the CBS+/- exercise group (Figure
15).
HHcy Promotes Inflammation in CBS+/- Skeletal Muscle
PPAR-γ protein expression, a pro-antioxidant factor, is significantly
decreased in the skeletal muscle of CBS+/- controls compared to C57 controls
(14% lower). Interestingly, it is significantly declined in CBS+/- and C57 exercise
groups when compared to their respective control counterparts. Protein
expression of IL-1β, a pro-inflammatory cytokine, is significantly increased in
CBS+/- control gastrocnemius tissue compared to C57 controls (46% higher).
Interestingly, there is a trend suggesting that these molecules may increase in
the muscle with exercise in both groups, but due to variability, neither of these
values are significantly different from their controls (Figure 16).
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Figure 6: Elevated plasma Hcy levels in CBS +/- mice are decreased with
exercise. Representative dot blot image of Hcy levels in mouse plasma samples.
Plasma Hcy levels were significantly higher in CBS NE compared to C57 NE (p<
0.001); these levels were decreased in CBS ET compared to CBS NE (p< 0.001).
Plasma Hcy was also lowered in C57 ET mice compared with C57 NE (p<
0.005). Band density was quantitated using BioRad Image Lab software. Data
are shown as ± SEM. n= ≥ 3.
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Figure 7: HHcy leads to decreased body mass and muscle mass, but is
mitigated by exercise training. The above data show that A) CBS +/- mice
have lower body weight compared to all other mouse groups used; B) exercise
training mitigates the weight difference between CBS+/- and WT; and C) TA
mass is significantly lower in CBS +/- NE when compared to C57 NE, but
exercise training mitigates this weight difference. Data are displayed as mean ±
SEM. n= ≥ 3; p< 0.05. * = different from corresponding control group; # =
different from C57 NE.
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Figure 8: Exercise training mitigates HHcy induced hypertension. The
above data are a representation of mean blood pressure measures for all mouse
groups at baseline, after 6 weeks of control and after 6 weeks of exercise. CBS
+/- mice have significantly higher mean blood pressure than every other group at
baseline and this is completely mitigated after 6 weeks of exercise. Data are
represented as mean ± SEM. n ≥ 3; p< 0.05. * = different from corresponding
control group; # = different from C57 NE.
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Figure 9: HHcy causes impaired hind limb perfusion that is mitigated with
exercise training. Femoral artery perfusion is decreased in CBS NE compared
to C57 NE and is significantly increased with exercise. Flux was measured using
a laser Doppler imager. Data are represented as mean ± SEM. n ≥ 3; p< 0.05;
* = different from corresponding control group; # = different from C57 NE.
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Figure 10: HHcy causes an increased wall to lumen ratio and a decreased
lumen diameter, but these effects are reversed with exercise training. At
baseline, CBS +/- mice have a significantly higher femoral artery A) wall to lumen
ratio and significantly lower B) lumen diameter when compared to C57 preexercise. Exercise mitigates these effects. Data are represented as mean ±
SEM. n ≥ 3; p< 0.05.
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Figure 11: Exercise training mitigates HHcy induced skeletal muscle
fibrosis. Control CBS +/- mice have a significantly higher % of total collagen in
the gastrocnemius than every other group. Exercise training reverses this. FVB,
MMP-9 and CBS/MMP-9 control groups all have higher total collagen content
than C57 NE. These are FVB based, which is a different mouse breed. Data are
represented as mean ± SEM. n ≥ 3; p< 0.0005 vs C57 NE and CBS ET.
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Figure 12: HHcy causes decreased oxidative metabolism in skeletal
muscle, but it is improved by exercise. Cytochrome C oxidase mRNA
expression is lower in control CBS +/- gastrocnemius muscle compared to C57
control. Exercise training increases Cytochrome C oxidase expression in CBS +/mice. The mRNA expressions were determined through densitometry analysis.
Data are represented as mean ± SEM. n ≥ 4; p< 0.0005; 0.05, vs C57 NE and
CBS ET, respectively. * = different from corresponding control group; # =
different from C57 NE
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Figure 13: HHcy alters skeletal muscle growth regulators and exercise
training reverses the effects. A) Myostatin protein expression is elevated in
CBS NE gastrocnemius compared to C57 NE and the expression is normalized
with exercise. B) Follistatin expression is increased in C57 and CBS mice with
exercise in comparison to their respective controls. Densitometry analysis was
used for band quantitation. Data are represented as mean ± SEM. n ≥ 4; p< 0.01,
0.05 for CBS NE vs C57 NE and CBS NE VS CBS ET, respectively for
myostatin. p< 0.01 for CBS ET vs CBS NE for follistatin. * = different from
corresponding control group; # = different from C57 NE
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Figure 14: HHcy induces hypoxia in skeletal muscle. VEGF and iNOS protein
expression are elevated in control CBS +/- mice when compared to C57 NE,
indicating baseline hypoxia. Exercise decreases VEGF expression in CBS +/mice to C57 NE levels. Band density was determined through densitometry
analysis. Data are represented as mean ± SEM. n ≥ 4; p< 0.0001, 0.0005 for
CBS NE vs C57 NE and CBS NE VS CBS ET, respectively for VEGF. p< 0.005
for CBS NE vs C57 NE for iNOS.
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Figure 15: Exercise training mitigates HHcy induction of EMMPRIN and
MMP-9. A) EMMPRIN protein and MMP-9 B) protein and C) mRNA are induced
in control CBS +/- gastrocnemius compared to C57 NE. Exercise causes a
significant decrease in all three of these values. Data are represented as mean ±
SEM. n ≥ 4; p< 0.005, 0.05 for CBS NE vs C57 NE and CBS NE VS CBS ET,
respectively for EMMPRIN. p< 0.005, 0.05 for CBS NE vs C57 NE and CBS NE
VS CBS ET, respectively for MMP-9. p< 0.05, 0.01 for CBS NE vs C57 NE and
CBS NE VS CBS ET, respectively for MMP-9 mRNA.
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Figure 16: HHcy creates inflammatory environment in skeletal muscle.
A) PPAR-γ protein expression is reduced and B) IL-1β protein expression is
increased in CBS+/- mice compared with C57 NE. Data are represented as
mean ± SEM. n ≥ 4; p< 0.0005 for CBS NE vs C57 NE for PPAR-γ. p< 0.005 for
CBS NE vs C57 NE IL-1β.
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Discussion
HHcy is implicated in diseases such as atherosclerosis, heart disease and
diabetes and is thought to cause multi-organ damage (Bortolotto et al., 1999;
Miller et al., 2000; Signorello et al., 2007; Sutton-Tyrrell et al., 1997; Zheng et al.,
2013). Recent research has demonstrated that HHcy results in impaired
responsiveness to ischemia/reperfusion injury, lower muscle strength and
functionality, increased fatigability and lower muscle ATP levels (Swart et al.,
2013; Sudhakar Veeranki et al., 2014; S. Veeranki et al., 2015). However, the
effects of regular exercise on cardiovascular disease and skeletal muscle
function are known to be very beneficial. It has also been established that
exercise has the capability of reducing homocysteine levels (Neuman et al.,
2013; Randeva et al., 2002). Nevertheless, despite the abundance of research
on HHcy, there is very little information available regarding the molecular
changes that HHcy induces in the skeletal muscle tissue and there is even less
information available regarding the effects of exercise on these changes .The
present study demonstrates that HHcy induces skeletal muscle fibrosis through
induction of inflammatory factors and impairment of perfusion. This study
demonstrates that exercise is capable of attenuating most of these effects.
In this study, CBS +/- (HHcy) mice displayed a 13.2% decrease in body
weight, decreased skeletal muscle weight and a 42% increase in plasma
homocysteine levels when compared to C57 (WT) mice. These findings agree
with previous clinical studies that found patients with HHcy due to genetic defects
to have a significant reduction in body weight and muscle mass (Kalra et al.,
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1985; Kanwar et al., 1976). Dot blot analysis determined that CBS +/- mice do in
fact have a 42% greater concentration of plasma homocysteine and
homocysteinylated proteins when compared to C57 mice. CBS +/- mice also
demonstrated a significant elevation in mean blood pressure, placing them well
above normal levels (122 mmHg). Not surprisingly, this elevation in blood
pressure was accompanied by significant reductions in luminal diameter and
perfusion of the femoral artery as well as a significant increase in wall to lumen
ratio. This data indicates that HHcy is likely inducing adverse remodeling of the
vascular smooth muscle, causing a thicker and less compliant vascular wall
which will cause elevated blood pressure. Our data agrees with previous findings
from our laboratory that suggests that CBS +/- mice demonstrate a blunted
response to ischemia/reperfusion injury after femoral artery ligation (Veeranki et
al., 2014). The CBS +/- mice demonstrated impaired development of collateral
vessels in the ischemic hind limb due to impaired angiogenesis, which was
caused by blunted elevation of pro-angiogenic factors such as VEGF, HIF1-α and
PGC-1α. Our findings are also supported by other studies which demonstrate
that HHcy is associated with increased intraluminal thrombus thickness, aortic
stiffness, systolic hypertension and myocardial impairment (Bortolotto et al.,
1999; Sutton-Tyrrell et al., 1997; Wiernicki et al., 2011; Zheng et al., 2013).
Bortolotto et al. demonstrated that in 236 hypertensive patients, individuals with 2
or 3 sites of clinical vascular disease had significantly higher plasma
homocysteine levels than hypertensive patients with no clinical vascular disease
(Bortolotto et al., 1999). Accompanying impaired angiogenesis and vascular
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disease, other studies demonstrate that Hcy promotes the formation of ROS and
diminishes nitric oxide production in the vasculature, which are both associated
with impaired endothelial responsiveness and hypertension (Signorello et al.,
2007; Tyagi et al., 2009).
With HHcy causing impaired perfusion to the hind limb and skeletal
muscle weakness, it would seem likely that the skeletal muscle in CBS +/- mice
would display signs of fibrosis. Indeed, this study demonstrated that the CBS +/gastrocnemius muscle displayed a 6 fold increase in skeletal muscle collagen
deposition when compared to C57 controls. Excessive collagen deposition, which
is a hallmark of muscular fibrosis, leads to increased rigidity and decreased
functionality of skeletal muscle (Dodd et al., 2014; Gillies & Lieber, 2011). These
findings support other studies that suggest that HHcy induces skeletal muscle
weakness and impaired functionality, which could clearly be caused by muscular
fibrosis (Swart et al., 2013; Veeranki et al., 2015).
Interestingly, this data demonstrates that with implementation of a 6 week
treadmill exercise program these CBS +/- mice demonstrate increased weight
gain, muscle mass, femoral artery perfusion and lumen diameter. This study
also found a complete reversal of the plasma homocysteine levels, hypertension
and collagen deposition as well as a decrease in the CBS +/- wall to lumen ratio.
Furthermore, CBS/MMP-9 double KO mice did not exhibit any of these issues.
CBS/MMP-9 mice are normal weight and have normal blood pressure, perfusion
and wall to lumen ratio as well as significantly lower collagen deposition in the
skeletal muscle than observed in the CBS +/- mice. Although there were
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insufficient plasma samples for statistical analysis, it appears that the CBS/MMP9 mice have similar homocysteine levels to the CBS +/- mice (1.45 vs 1.43 fold
increase compared to C57 control, respectively). This data suggests that Hcy
elicits the majority of its associated pathologies through hyperactivity of MMP-9,
which is known for its ability to degrade the ECM.
The findings that exercise reverses the effects of HHcy on skeletal
muscle dysfunction agree with other studies that exercise decreases or prevents
increases in plasma Hcy levels (Neuman et al., 2013; Randeva et al., 2002).
Data from this study supports findings from the lab’s previous study, which
suggests that swimming exercise can attenuate the effects of HHcy on the downregulation of mitochondrial transcription factors and ATP production in the
skeletal muscle (Veeranki et al., 2015). This evidence suggests that CBS +/mice have impaired skeletal muscle metabolism when compared to control mice
and that exercise can improve its metabolic function. This study further supports
this theory by demonstrating that CBS +/- mice have a decrease in
gastrocnemius cytochrome c oxidase mRNA expression compared to C57
controls. It was found that exercise completely reverses this metabolic deficit.
With a decreased mass, elevated fibrosis and impaired metabolic activity
in CBS +/- skeletal muscle, I wanted to determine whether or not the skeletal
muscle growth was being impaired by changes in molecular growth factors. The
data suggests that CBS +/- gastrocnemius muscle had a 2 fold increase in
expression of myostatin protein, a muscle growth inhibitor, when compared to
C57 controls. CBS/MMP-9 myostatin expression was significantly lower than
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levels in CBS +/- mice and was not different from levels in C57 controls, once
again confirming that MMP-9 induction is likely the mechanism of action for
HHcy. As expected, myostatin levels in CBS +/- mice were significantly reduced
with exercise and were reduced to the same levels as seen in exercised C57
mice, which correspond well with the findings that exercise increases follistatin
mRNA expression in CBS +/- mice. Interestingly, there was an observed increase
in myostatin levels in C57 exercise mice compared to their control counterparts.
The observed significant increase in follistatin mRNA expression, a known
inhibitor of myostatin, in C57 mice with exercise suggests that myostatin may be
over-expressed in C57 mice post-exercise due to positive feedback loops from
myostatin inhibition during exercise. This exercise protocol was designed for
moderate to high intensity by the end of the protocol to ensure muscular
hypertrophy as seen in some resistance training programs. Findings that
myostatin increased in the skeletal muscle of C57 mice with exercise training is
supported by findings from Willoughby, 2004. This author found that 12 weeks of
resistance training in 22 healthy males resulted in elevated body mass, muscle
mass and strength, but also demonstrated increases in myostatin mRNA,
myostatin and follistatin-like related gene, another inhibitor of myostatin
(Willoughby, 2004). Furthermore, unchecked myostatin levels, as seen in control
CBS +/- mice, has been shown to directly increase fibroblast activity, which in
turn, increases macrophage activity (McCroskery et al., 2005; Vidal et al., 2008).
Seeing as both macrophages and fibroblasts are implicated in muscular fibrosis,
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it makes sense that control CBS +/- mice, which over-express myostatin, would
have fibrotic muscle tissue.
The findings that VEGF and iNOS are induced in the gastrocnemius
muscle of control CBS+/- mice and exercised C57 mice is not surprising, as both
are commonly induced during states of hypoxia, including exercise (Forsythe et
al., 1996; Hambrecht et al., 1999; Richardson et al., 1999; Richardson et al.,
2000; Shweiki, Itin, Soffer, & Keshet, 1992; Vogt et al., 2001). However, it was
interesting to see that VEGF was decreased to C57 control levels in exercise
CBS+/- mice. A study from Richardson et al. demonstrates that exercise training
causes a reduction in VEGF stimulation when exposed to hypoxic conditions,
suggesting that VEGF stimulation has a negative feedback mechanism
(Richardson et al., 2000). It is plausible that CBS +/- muscle tissue has become
insensitive to VEGF stimulation and with training, angiogenesis has occurred
through an elevated stimulation of other angiogenic factors such as fibroblast
growth factor, causing a decline in VEGF necessity. Furthermore, an increased
capillary to fiber ratio, as observed with exercise training, would decrease the
basal level of hypoxia in the muscle tissue, resulting in a decrease in VEGF
production.
As expected with HHcy, MMP-9 mRNA and protein expression as well as
protein expression of its inducer, EMMPRIN, were all significantly elevated in
CBS+/- mice when compared to C57 controls. Interestingly, EMMPRIN and
MMP-9 protein levels are both significantly increased with exercise training in
C57 mice. Although MMP-9 has been associated with numerous diseases, it has
73

also been demonstrated that MMP-9 assists with satellite cell translocation
(Kherif et al., 1999; Lewis et al., 2000; Zimowska et al., 2008) and may be
required for the onset of angiogenesis (Bellafiore et al., 2013; Mackey et al.,
2004; Rullman et al., 2009). However, this does not explain why EMMPRIN and
MMP-9 protein expression is decrease in exercise CBS+/- mice compared to
control CBS+/-. Seeing as exercise decreased these values to levels that are
almost identical to exercised C57 values, it would seem that basal levels of these
proteins in CBS+/- mice were more than sufficient to accomplish necessary
growth associated tasks for exercise, allowing for normalization of their values.
Although protein expression of MMP-9 went up with exercise in C57 mice, the
data demonstrates a decrease in MMP-9 mRNA values. Since the animals were
sacrificed 2 days post-exercise to allow time for blood pressure and
ultrasonography data to be collected, it is plausible that the elevated MMP-9
protein expression elicited a reduction in MMP-9 mRNA via negative feedback
during that time frame.
To assess other markers of inflammation, changes in IL-1β, a proinflammatory cytokine, and PPAR-γ, a pro-antioxidant, protein expressions in the
gastrocnemius tissue were measured. In CBS+/- mice, IL-1β was elevated and
PPAR-γ was decreased when compared to C57 control mice, as expected with
HHcy. It is well known that Hcy induces inflammation and it has been
demonstrated that it also inhibits PPAR-γ (Mujumdar et al., 2002). Interestingly,
this data suggests that PPAR-γ is decreased with exercise in both C57 and CBS
+/- groups. These results agree with a data from Tunstall et al. that demonstrated
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a significant reduction in PPAR-γ in human vastus lateralis muscle after 9 days of
60 minute cycling bouts (Tunstall et al., 2002). With exercise requiring
inflammation for proper growth and repair during the recovery phase, as seen in
elevated levels of MMP-9 and EMMPRIN, it is plausible that a potent proantioxidant like PPAR-γ would be down-regulated to allow for adequate induction
of the inflammatory process. Although the elevations are insignificant, the slight
increases in IL-1β observed with exercise would support this theory.
In summary, results of this study indicate that HHcy causes muscle
dysfunction that is induced through multiple anti-proliferative and inflammatory
factors such as myostatin, EMMPRIN and MMP-9. It would appear that MMP-9 is
a primary pathway through which HHcy causes pathological conditions since
CBS/MMP-9 double KO mice have elevated Hcy levels, but do not display any of
the pathological conditions that are witnessed in CBS+/- mice. Furthermore,
exercise was capable of mitigating most of the pathological complications
associated with HHcy. Clearly, further research on the exact mechanism of
action for HHcy induced skeletal muscle dysfunction needs to be conducted.
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CHAPTER V
THE EFFECT OF HYPERHOMOCYSTEINEMIA ON MACROPHAGE
DIFFERENTIATION AND SKELETAL MUSCLE INFILTRATION

Introduction
Homocysteine has been widely identified as a risk factor in numerous
disease states. HHcy, demonstrating plasma Hcy levels >15 µmol/L, has known
prevalence in hypertension, stroke, cardiovascular disease and skeletal muscle
dysfunction (Bortolotto et al., 1999; Hayden & Tyagi, 2004; Mujumdar et al.,
2002; Signorello et al., 2007; Sutton-Tyrrell et al., 1997; Tyagi et al., 2005;
Veeranki & Tyagi, 2013). Research has shown a direct correlation between
plasma Hcy levels and aortic pulse wave velocity, intraluminal thrombus
thickness and arterial stiffness.
It is well established that Hcy elicits many of its detrimental effects through
increased ROS production and through induction of MMP-9 (Hayden & Tyagi,
2004; Lee et al., 2012; Signorello et al., 2007; Tyagi et al., 2009). MMP-9 is an
endoproteinase that is known to degrade components of the extracellular matrix,
such as elastin and collagen type IV. Excessive MMP-9 activity has been
associated with endothelial dysfunction and vascular
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remodeling, leading to diseases such as atherosclerosis (Onal et al., 2009;
Wiernicki et al., 2011; Yasmin et al., 2005). More recently it has been discovered
that MMP-9 production and activity are increased through an EMMPRIN
mediated pathway involving NF-κB (Ge et al., 2007; Major et al., 2002; Reddy et
al., 2010; Yoon et al., 2005; Zhu et al., 2005). EMMPRIN is a glycoprotein that
can be induced through inflammatory factors such as IL-18. In a study involving
human carotid endarterectomy specimens, significant EMMPRIN
immunoreactivity was displayed in atherosclerotic carotid lesions, arterial plaque
and in macrophage infiltrates of the atherosclerotic intima (Yoon et al., 2005).
This same study also examined the effects of atherogenic pro-inflammatory
cytokines (TNF-α, IL-6 and IL-1β) on cultured human bone marrow monocytes
and discovered increased expression of EMMPRIN protein and increased MMP9 activity.
With the numerous pathological effects of HHcy revolving around ECM
degradation, vascular remodeling, cardiovascular disease and inflammation, it is
important to ponder the effects of Hcy on macrophages, the body’s main innate
immune cells. It is well established that macrophages have two specific
subtypes, denoted as M1 and M2. The M1 phenotype is the destructive,
“classically activated” subset, while the M2 is called the “alternatively activated”
subset, associated with growth and repair (Mills, 2012; Sica & Mantovani, 2012).
Although classically activated macrophages are important for fighting infections,
previous research has demonstrated that excessive macrophage differentiation
into the M1 phenotype can cause chronic adipocyte inflammation, neurotoxicity
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to injured nerves and damage the arterial vasculature (Kigerl et al., 2009; Oh et
al., 2012; Tavakoli & Asmis, 2012; Zeyda et al., 2007). It has been demonstrated
that M1 macrophages elicit their inflammatory and damaging effects through a
rapid production of ROS, NO and MMP-9 (Mills, 2012; Sica & Mantovani, 2012;
Woo, Lim, & Kim, 2004). Interestingly, It has been demonstrated that Hcy
induces vascular endothelial growth factor expression and monocyte
chemoattractant protein-1 via an NF-κB dependent pathway in THP-1
macrophages, which are both associated with vascular disease progression
(Wang et al., 2001). There are several markers that have been used to detect M1
and M2 macrophages, however, Vogel et al. clearly demonstrate that CD40, a
cell surface co-stimulatory protein found on macrophages, is a highly effective
marker for detection of the M1 phenotype (Vogel et al., 2013).
In the skeletal muscle, macrophages are crucial for proper growth and
repair. Once macrophages phagocytose muscle cell debris, they shift towards
and anti-inflammatory profile, causing the release of TGF-β and bFGF, which
stimulates muscle satellite cell migration (Arnold et al., 2007; Robertson et al.,
1993). Injury to the skeletal muscle elicits significant increases in macrophage
infiltration for 3 days post injury then these levels begin to subside by day 6
(Pimorady‐Esfahani et al., 1997). If monocyte recruitment to the site of damaged
skeletal muscle is interrupted within the first 24 hours post-injury, the repair
process is completely attenuated. Inflammatory macrophages stimulate
myogenic cell proliferation, while anti-inflammatory macrophages stimulate
myogenic cell differentiation into myotubes (Arnold et al., 2007). Complete
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removal of macrophages after muscular injury decreases the diameter of
regenerating muscle fibers (Arnold et al., 2007; Chazaud et al., 2009). Research
demonstrates that exercise stimulates the phagocytic activity of macrophages
(De la Fuente et al., 1990; Ferrandez & De la Fuente, 1999). However, the
effects of exercise on macrophage differentiation and infiltration into the skeletal
muscle, especially in a chronically inflammatory environment, have not been
well-documented. Kawanishi et al. demonstrated that mice being fed a high fat
diet display a greater ratio of adipose tissue M1/M2 macrophages compared to
normal diet controls (Kawanishi et al., 2010). After 16 weeks of exercise training,
there was a decreased ratio of M1/M2 macrophages in the high fat diet group
due to increased presence of M2 macrophages. This was accompanied by a
decrease in TNF-α mRNA expression, which is only expressed by M1
macrophages.
There have been no other studies that determine whether Hcy alters
macrophage differentiation through EMMPRIN or if chronic HHcy leads to
increased M1 macrophage infiltration into skeletal muscle. Therefore, it is the
purpose of this study to determine the effects of homocysteine on the phenotypic
differentiation of macrophages and whether or not it increases M1 macrophage
presence in skeletal muscle tissue.
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Methods
Chemicals and Antibodies
L-homocysteine was purchased from Sigma-Aldrich (St. Louis, MO).
EMMPRIN, CD40, F4/80 and all HRP-conjugated secondary antibodies were
purchased from Santa Cruz Biotechnology (Dallas, TX). GAPDH antibody was
purchased from EMD Millipore (Billerica, MA). MMP-9 and TNF-α antibodies
were purchased from Abcam (Cambridge, MA) and fluorescent secondary
antibodies were purchased from Life Technologies (Carlsbad, CA).

Animal Care and Exercise Protocol
C57 and CBS +/- mice were used for this study. Animal care and the
exercise protocol are as previously described in Chapter IV.

Cell Culture
J774A.1 and Raw 264.7 murine macrophages cell lines were obtained
from ATCC (Manassas, VA). Cells were grown in 75cm2 flasks using ATCC 302002 Dulbecco’s Modified Eagles Medium (DMEM) supplemented with 10% fetal
bovine serum (FBS) and 1% final volume penicillin-streptomycin solution. Cells
were maintained in a 37 °C incubator with 5% CO2 and passaged by scraping
cells into fresh medium per ATCC recommendations.
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Cell Treatment
Cells were plated in 6 well plates at a count of 750K cells per well for
harvesting of protein or in 8 well chamber slides at a count of 150K cells per
chamber for Immunocytochemistry. After 24 hours of incubation, to allow for
proper plate adherence, the medium was aspirated and fresh medium was added
to each well. Homocysteine treatment was added directly to the medium at a
final concentration of 500μM for Raw 264.7 cells and 100μM for J774A.1 cells.
Cells were then incubated with Hcy treatment for 24 hours.

Western Blot Analysis
Gastrocnemius tissue was used for protein analysis. For cell culture
experiments, cells were harvested 24 hours after Hcy treatment for protein
analysis. The DMEM medium was aspirated and cells were then washed twice
with PBS. Cells or gastrocnemius tissues were then lysed in RIPA lysis buffer,
supplemented with a protease inhibitor cocktail, PMSF and sodium
orthovanadate, for 15 minutes on ice. For cell culture, each well was then
scraped and contents were transferred to an Eppendorf tube. Cell culture and
gastrocnemius lysates were then sonicated for 5 seconds each and then
centrifuged at 8,000 RPM for 10 minutes. Precipitates were then transferred to a
new tube. Protein concentrations were determined via Bradford protein
estimation assay to ensure equal protein loading then samples were run on an
SDS poly-acrylamide gel in Tris-glycine SDS buffer for proper protein separation
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and were then transferred electrophoretically onto a PVDF membrane overnight
at 4 degrees. The membrane was blocked in a 5% milk TBST solution for 1
hour. All primary antibodies were diluted at a concentration of 1:1000 in TBST
and membranes were incubated with primary antibody solution overnight at 4
degrees. After primary incubation, the membranes were washed three times with
TBST solution then incubated with a secondary HRP conjugated antibody
solution for 1 hour at room temperature. Membranes were then washed three
more times with TBST then developed using a chemiluminescent substrate in a
BioRad Chemidoc (Hercules, CA). Band intensity was determined using
densitometry analysis.

DCFDA ROS Assay
To detect changes in ROS production levels between control and Hcy
treated cells, cells were aspirated 24 hours post treatment and fresh medium
containing 20μM 2’,7’ –dichlorofluorescin diacetate (DCFDA) was added to each
well. For EMMPRIN inhibition ROS assay, anti-EMMPRIN antibody was diluted
1:200 in complete DMEM medium and added 2 hours prior to treatment. Cells
were incubated with DCFDA at 37 degrees for 30 minutes. The medium was then
aspirated and each well was washed 3 times with PBS. Fresh PBS was then
added to each well and the cells were imaged using confocal microscopy.
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Immunocytochemistry
After cell treatment, the medium was aspirated from each well of the
chamber slides and they were then washed twice with PBS. Cells were then fixed
using a 4% paraformaldehyde solution for 15 minutes at room temperature,
which was followed by 3 washes with PBS. A PBS solution with 3% BSA and
0.3% Triton X-100 was used to block non-specific binding and permeabilize the
cells for 1 hour. Primary antibody was then added in a concentration of 1:50 for
CD40 and 1:200 for MMP-9 in a PBS solution containing 1% BSA and 0.1% TX100 and was incubated overnight at 4°C. The chamber slides were aspirated,
washed 3 times and then incubated with fluorescent secondary antibody (1:200)
for 2 hours at room temperature. Chambers were then washed 3 times and then
a DAPI staining solution was added for 5 minutes, followed by 3 more washes.
Confocal Microscopy was then used to detect fluorescence.

EMMPRIN Antibody Treatment
To assess the role of EMMPRIN on M1 macrophage differentiation, prior
to homocysteine treatment, EMMPRIN antibody was added in a final
concentration of 1:200 directly to the cell culture medium to inhibit EMMPRIN
function. Cells were allowed to incubate with antibody for 2 hours and then the
homocysteine treatment was administered as described above.
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Immunohistochemistry
Tissues were cryo-sectioned onto poly-L-lysine coated glass microscope
slides and allowed to air dry. Slides were stored at -80°C until use. Slides were
dipped in deionized water to remove tissue freezing medium from slide. Tissue
sections were then fixed using a 4% paraformaldehyde solution for 15 minutes at
room temperature, which was followed by 3 washes with PBS. A PBS solution
with 3% BSA and 0.3% Triton X-100 was used to block non-specific binding and
permeabilize the cells for 1 hour. Primary antibody was then added in a
concentration of 1:50 in a PBS solution containing 1% BSA and 0.1% TX-100
and was incubated overnight at 4°C. The slides were then washed 3 times and
then incubated with fluorescent secondary antibody (1:200) for 2 hours at room
temperature. Slides were then washed 3 times and then a DAPI staining solution
was added for 5 minutes, followed by 3 more washes. Confocal Microscopy was
then used to detect fluorescence. Fluorescent intensity was then quantitated
using Image J software (NIH).
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RESULTS
Hcy treatment induces EMMPRIN expression
Since EMMPRIN is suggested to be an inducer of matrix
metalloproteinases, we decided to look at changes in EMMPRIN protein
expression with Hcy treatment in these cells lines. Western blotting was used to
determine changes in EMMPRIN expression. EMMPRIN was significantly
increased in RAW 264.7 cells with 24 hours of 500 μM Hcy treatment when
compared with controls (p< .001). In J774A.1 cells, a significant induction (p<
.05) of EMMPRIN protein with 24 hours of 100 μM Hcy treatment was also
observed (Figure 17); n=3.

Hcy treatment induces ROS production in macrophages
Since M1 macrophages are associated with increased reactive oxygen
species (ROS) production, we utilized a DCFDA (2’,7’ –dichlorofluorescin
diacetate) assay to determine if Hcy treatment causes increased ROS production
in both strains of murine macrophages. Both RAW 264.7 and J774A.1 cells
demonstrated increased ROS production (p< .05; p< .01) after 24 hours of
500μM and 100μM Hcy treatment respectively, when compared with controls
(Figure 18); n=3.
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Hcy treatment induces MMP-9 protein
To determine whether or not MMP-9 was elevated in Hcy treated cells,
immunocytochemistry (ICC) was performed on both cell lines to determine
changes in expression of MMP-9 protein. After 24 hours of 100μM Hcy
treatment, the J774A.1 cells displayed a significantly higher (p< .05) production
of MMP-9 protein when compared with controls. Raw 264.7 cells incubated with
500μM Hcy treatment for 24 hours also displayed elevated levels of MMP-9
protein (p< .05). Fluorescent intensity was measured to quantitate these
increases in MMP-9 production (Figure 19); n=3.

HCY Treatment Induces CD40 in murine macrophages
To determine the effect of Hcy on macrophage phenotype differentiation,
J774A.1 and Raw 264.7 cells (mouse macrophage cell lines) were stimulated
with Hcy treatment for 24 hours. Cells were harvested and lysed for protein
analysis and analyzed through western blotting. CD40 was significantly
increased (p<0.05) in J774A.1 cells with 100μM Hcy treatment. The Raw 264.7
cells were not as sensitive to Hcy treatment as the J774A.1 cell line, but
displayed a significant 2.24 fold increase (p< 0.0001) in CD40 protein with 500uM
Hcy treatment (Figure 20); n=3.
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Inhibiting EMMPRIN activity decreases the M1 macrophage phenotype
In order to determine if EMMPRIN is involved in differentiation of
macrophages into the M1 phenotype, we decided to see if blocking EMMPRIN
function would impact CD40 protein expression. RAW 264.7 and J774A.1 cells
were incubated with anti-EMMPRIN antibody for 2 hours prior to no HCY
treatment or 24 hours of 500 μM and 100 μM HCY treatment respectively. Raw
264.7 cells receiving anti-EMMPRIN antibody pretreatment with no Hcy treatment
had significantly reduced (p< .001) CD40 protein expression compared to control.
Cells receiving pre-treatment with anti-EMMPRIN antibody and treatment with
Hcy also displayed a decreased expression of CD40 (p< .005). No difference
was found between the two treatment groups. J774A.1 cells receiving antiEMMPRIN antibody pretreatment with no Hcy treatment had significantly lower
(p< .005) CD40 protein expression than controls. Cells receiving pre-treatment
with anti-EMMPRIN antibody and treatment with Hcy also displayed a decreased
expression of CD40 (p< .005). No difference was found between the two
treatment groups (Figure 21); n=3.

EMMPRIN Inhibition Reduces ROS Production in J774A.1 Cells
Pre-treatment of J774A.1 cells led to a significant decline in ROS
production when compared to controls. As expected, 100 µM Hcy treatment
elicited a significant, almost 2 fold, increase in ROS production compared to
control. However, when Hcy treated cells were pre-treated with anti-EMMPRIN
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antibody, ROS production was reduced to control levels. This indicates that
EMMPRIN mediates Hcy induced ROS production in J774A.1 macrophages
(Figure 22); n=3.

Exercise Decreases M1 Macrophage Infiltration in CBS+/- Skeletal Muscle
F4/80 is a cell surface protein that is only found on macrophages and
monocytes. It is commonly used to detect macrophage populations within other
tissues. TNF-α is present in skeletal muscle, but it has been documented that the
vast majority of TNF-α expressed in skeletal muscle is produced by
macrophages (Hamada, Vannier, Sacheck, Witsell, & Roubenoff, 2005). Colocalization of F4/80 and TNF-α is indicative of an M1 macrophage population
since TNF-α is only expressed by M1 macrophages. Immunohistochemistry for
co-localization of TNF-α and F4/80 protein expression in gastrocnemius muscle
sections indicated that TNF-α and F4/80 protein expression were significantly
increased in CBS +/- mice when compared to C57 controls and exercise
intervention caused a significant decline in CBS +/- TNF-α expression. Although
F4/80 expression did not significantly decrease in CBS +/- mice with exercise, it
was no longer significantly different from C57 control values, indicating a slight
reduction in the number of macrophages. Although TNF-α demonstrated a slight
decline in C57 mice with exercise, the values were not significant when
compared with C57 control. No changes in F4/80 protein expression were
observed in C57 mice with exercise (Figure 24); n=4.
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(Winchester, Veeranki, Givvimani, & Tyagi, 2015)
Figure 17: Hcy increases EMMPRIN expression in macrophages. EMMPRIN
protein expression is significantly increased in A) Raw 264.7 cells and B)
J774A.1 cells by 24 hours of 500µM or 100µM Hcy treatment, respectively.
Bands were quantitated using densitometry. Data is presented as the means +
SEM. n = 3; p< 0.001; p< 0.05 respectively.
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(Winchester et al., 2015)
Figure 18: Hcy increases ROS production in macrophages. ROS production
is significantly increased in A) Raw 264.7 cells and B) J774A.1 cells by 24 hours
of 500µM or 100µM Hcy treatment, respectively. DCFDA assay was used to
detect ROS production. Data is presented as the means + SEM. n = 3; p< 0.05;
p< 0.01, respectively.
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(Winchester et al., 2015)
Figure 19: Hcy increases MMP-9 expression in macrophages. MMP-9
expression is significantly increased in A) Raw 264.7 cells and B) J774A.1 cells
by 24 hours of 500µM or 100µM Hcy treatment, respectively.
Immunohistochemistry was used to detect MMP-9. Data is presented as the
means + SEM. n = 3; p< 0.05; p< 0.05, respectively.
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(Winchester et al., 2015)
Figure 20: Hcy causes macrophages to shift towards an M1 phenotype.
CD40 protein expression, a marker for M1 macrophages, is significantly
increased in A) Raw 264.7 cells and B) J774A.1 cells by 24 hours of 500µM or
100µM Hcy treatment, respectively. Quantification was performed through
densitometry. Data is presented as the means + SEM. n = 3; p< 0.0001; p<
0.05, respectively.
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(Winchester et al., 2015)
Figure 21: Inhibition of EMMPRIN prevents M1 macrophage shift.
CD40 protein expression, is significantly increased in A) Raw 264.7 cells and B)
J774A.1 cells by inhibition of EMMPRIN with or without 24 hours of 500µM or
100µM Hcy treatment, respectively. Quantification was performed through
densitometry. Data is presented as the means + SEM. n = 3; p< 0.001; p<
0.005, respectively for Ab and Hcy 500µM + AB groups vs control in Raw 264.7
cells. p< 0.005; p< 0.005, respectively for Ab and Hcy 100µM + AB groups vs
control in J774A.1 cells.
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Figure 22: Inhibition of EMMPRIN decreases ROS production in
macrophages. ROS production is significantly decreased in J774A.1 cells by
inhibition of EMMPRIN with or without 24 hours of 100µM Hcy treatment.
Quantification was performed through densitometry. Data is presented as the
means + SEM. n = 3; p< 0.001, 0.05 and 0.0005 for Hcy 100µM vs Control, Ab
vs Control and Hcy 100µM + Ab vs Hcy 100µM, respectively.
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(Winchester et al., 2015)
Figure 23: Schematic representation of M1 shift through Hcy treatment.
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Figure 24: Exercise decreases the number of M1 macrohpages in CBS +/skeletal muscle. TNF-α (M1) and F4/80 (macrophage marker) expression are
increased in CBS +/- skeletal muscle. Exercise decreases TNF-α expression in
CBS +/- mice, indicating a lower population of M1. Data is presented as the
means + SEM. n = 4; p< 0.05 for CBS NE vs C57 NE for F4/80. p< 0.01, 0.01 for
CBS NE vs C57 NE and CBS ET vs CBS NE, respectively, for TNF-α.
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DISCUSSION
The primary finding of this present study is that Hcy treatment causes
macrophages to differentiate into a “classically activated,” M1 phenotype as
determined by increased CD40 and MMP-9 expression, as well as elevated ROS
production. It was found that inhibiting EMMPRIN activity, an inducer of MMP-9,
resulted in reduced levels of CD40 in murine macrophages. This finding suggests
that Hcy induced macrophage differentiation into M1 phenotype is facilitated, at
least in part, by an EMMPRIN mediated pathway.
Due to its strong association with a variety of pathological conditions,
many of the consequential effects of HHcy are well-explored (Bortolotto et al.,
1999; Naess et al., 2013; Signorello et al., 2007; Tyagi et al., 2005; Veeranki &
Tyagi, 2013; Zheng et al., 2013). Hcy associated vascular inflammation and
remodeling is largely due to increased ROS (Hayden & Tyagi, 2004; Signorello et
al., 2007) and MMP-9 production (Moshal et al., 2006; Tyagi et al., 2009) as well
as an inhibition of peroxisome proliferator-activated receptor-γ (PPAR-γ), a proantioxidant (Mujumdar et al., 2002). MMP-9 is activated by Hcy through an
extracellular signal-regulated kinase (ERK) pathway in vascular endothelial cells
(Moshal et al., 2006; Tyagi et al., 2009) and is thought to be a primary factor in
vascular remodeling and arterial stiffness (Onal et al., 2009; Wiernicki et al.,
2011; Yasmin et al., 2005). However, studies have shown that extracellular
matrix metalloproteinase inducer (EMMPRIN) activation not only correlates with
MMP activity, but may be largely responsible for increased synthesis of MMP-9
(Ge et al., 2007; Major et al., 2002; Reddy et al., 2010; Yoon et al., 2005; Zhu et
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al., 2005). It was found that co-localization of macrophages with EMMPRIN and
MMP-9 occurs in areas of vascular inflammation. Wang et al. suggest that Hcy
elicits monocyte chemotaxis through induction of monocyte chemoattractant
protein-1(Wang et al., 2001). Moreover, it was found that a high concentration of
Hcy enhances MMP-9 production in murine macrophages (Lee et al., 2012).
These findings led to further investigations to determine whether a pathological
concentration of Hcy leads to macrophage differentiation into the classically
activated, M1 phenotype.
CD40, a co-stimulatory protein, is a commonly used marker of M1
macrophages that has been described as a prevalent indicator of the M1
phenotype (Aron-Wisnewsky et al., 2009; Munder et al., 1998; Vogel et al.,
2013). The findings that a pathological dose of Hcy induces CD40 and MMP-9
protein expression in both J774A.1 and Raw 264.7 murine macrophage cell lines
suggest that Hcy is causing a shift towards the M1 phenotype. Our data
corresponds with another study which demonstrates that Hcy enhances MMP-9
production in J774A.1 cells via ERK and Akt signaling pathways (Lee et al.,
2012). Interestingly, other studies demonstrate that the pro-inflammatory
cytokine, IL-18, induces MMP-9 in cardiomyocytes via EMMPRIN activation of a
PI3K dependent Akt pathway (Reddy et al., 2010; Weisser et al., 2013). The
present study demonstrates that 0.1 or 0.5 mM Hcy treatment significantly
induces EMMPRIN protein synthesis in both J774A.1 and Raw 264.7
macrophages respectively. It has been established that EMMPRIN induction is
strongly associated with inflammatory conditions. EMMPRIN is readily expressed
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on human carcinoma cell surfaces, atheromas, pro-inflammatory cytokine
stimulated bone marrow monocytes and in atherosclerotic carotid lesions
(Gabison, Hoang-Xuan, Mauviel, & Menashi, 2005; Guo et al., 2000; Major et al.,
2002; Yoon et al., 2005). Due to its close association with these inflammatory
pathologies, I believe that EMMPRIN is at least partially involved in macrophage
differentiation into the M1 phenotype. To verify this, the effects of EMMPRIN
inhibition on CD40 expression were examined. As hypothesized, the inhibition of
EMMPRIN led to a decreased induction of CD40 in both murine macrophage cell
lines, with and without Hcy treatment. This suggests that M1 differentiation by
Hcy is at least partially reliant upon an EMMPRIN mediated pathway.
Homocysteine is associated with increased ROS production in various cell types
due to its auto-oxidative properties and through the production of mixed
disulfides (Hayden & Tyagi, 2004; Signorello et al., 2007). Interestingly, elevated
oxidative stress levels may result in a destructive M1 macrophage phenotype, as
detected by increased release of iNOS, TNF-α and pro-inflammatory cytokines.
Furthermore, it was found that increased EMMPRIN expression, resulting in
activation of MMP-9 and other inflammatory factors, is induced by elevated ROS
production (Siwik et al., 2008; Yuan et al., 2010). This supports the findings that
Hcy treatment results in an M1 macrophage phenotype through EMMPRIN,
leading to increased ROS production.
M1 macrophages are known to fight infections, cause neurotoxicity and
exacerbate atherosclerosis (El Hadri et al., 2012; Kigerl et al., 2009; Tavakoli &
Asmis, 2012). These tasks are accomplished through the release of pro99

inflammatory cytokines and MMP-9 as well as increased reactive nitrogen and
oxygen species production (de Pinho et al., 2014; Nishi et al., 2008; Sica &
Mantovani, 2012; Weisser et al., 2013; Woo et al., 2004). This study further
validated the Hcy induced shift towards the M1 phenotype by demonstrating
significantly increased ROS production in Hcy treated murine macrophages
through a DCFDA assay. Furthermore, it was demonstrated that inhibition of
EMMPRIN led to a significant reduction in ROS production in and that the effects
of HHcy on ROS production were completely mitigated when EMMPRIN was
blocked. These findings agree with a study by El Hadri et al., which
demonstrates a predominant population of M1 macrophages in severe
atherosclerotic lesions of ApoE2.Ki mice (El Hadri et al., 2012) that are reliant on
ROS production. These mice were challenged with lipopolysaccharide (a known
inducer of M1) for 5 weeks, causing them to develop atherosclerotic lesions.
However, when treated with thioredoxin-1, an anti-oxidative protein, the
macrophages in the lesions shifted predominantly to the M2 phenotype and the
area of aortic lesion was significantly reduced. The present study, which
suggests that CBS+/- gastrocnemius muscle has a greater M1 macrophage
population and that the number is reduced by exercise, is further supported by
the concept that anti-oxidative proteins cause a shift in macrophage phenotype
towards M2. Exercise is known to increase cellular anti-oxidative capacity, which
in turn helps to reduce muscular inflammation (Vincent et al., 2006). Decreased
levels of muscular inflammation with exercise in CBS +/- mice would explain the
observed reduction in M1 macrophage content in the CBS +/- skeletal muscle
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after training. Although was an observed decreased concentration of M1
macrophages in CBS +/- mice with exercise, it is not surprising that there was not
a significant reduction in overall macrophage presence (F4/80). It has been
documented that macrophages are capable of shifting phenotype within the
skeletal muscle, depending on the environment (Arnold et al., 2007; Chazaud et
al., 2009). Therefore, it is very plausible that the present M1 macrophages shifted
into an M2 phenotype or just became relatively inactive. Further research is
clearly needed to determine the changes occurring with intramuscular
macrophage populations with exercise and HHcy.
In summary, the present study demonstrates that Hcy causes murine
macrophages to shift into a classically activated M1 phenotype as determined by
CD40 expression. This stimulates EMMPRIN and MMP-9 synthesis as well as
increased ROS production. Furthermore, it was found that inhibition of EMMPRIN
leads to decreased CD40 in these cells, indicating a shift away from the M1
phenotype. Moreover, it is apparent that HHcy causes a greater M1 macrophage
population in the skeletal muscle and that this population shifts to a different
phenotype with exercise intervention. Altogether, these results suggest that Hcy
promotes an M1 macrophage phenotype through an EMMPRIN mediated
pathway and that exercise can mitigate the inflammatory state associated with
HHcy and M1 macrophages.
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CHAPTER VI
SUMMARY, CONCLUSION AND FUTURE DIRECTIONS

Hyperhomocysteinemia has been widely implicated in the development of
cardiovascular diseases such as hypertension, atherosclerosis, heart failure and
diabetes (Bortolotto et al., 1999; Signorello et al., 2007; Sutton-Tyrrell et al.,
1997; Wiernicki et al., 2011; Zheng et al., 2013). Elevated levels of inflammation,
including increased MMP-9 and ROS production are hallmarks of HHcy (Lee et
al., 2012; Signorello et al., 2007; Tyagi et al., 2009). Clinical studies of patients
with genetic defects that cause HHcy, such as MTHFR or CBS deficiency,
display decreased bodyweight and skeletal muscle mass (Kalra et al., 1985;
Kanwar et al., 1976). Research has demonstrated that HHcy translates to
impaired muscular strength and elicits functional limitations in humans and
animals (Swart et al., 2013; Veeranki et al., 2015). With this knowledge, there is
sufficient evidence that suggests that HHcy may induce chronic inflammation in
skeletal muscle leading to muscular dysfunction. However, the molecular
changes and mechanisms associated with this are still very unclear.
Furthermore, it has been demonstrated that exercise is capable of reducing
plasma Hcy levels (Neuman et al., 2013; Randeva et al., 2002). Therefore,
exercise would serve as a promising intervention for individuals with HHcy and
HHcy related pathologies.
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In the first set of experiments it was found that HHcy led to decreased
body mass and skeletal muscle perfusion in CBS +/- mice. It was found that the
skeletal muscle of these mice have significantly higher collagen deposition in the
skeletal muscle, indicating fibrosis, as well as increased levels of the growth
inhibiting factor, myostatin. This study showed that HHcy led to inflammation of
the skeletal muscle and that the remodeling likely occurs through elevated MMP9 levels via EMMPRIN induction. Interestingly, our CBS/MMP-9 double KO
mouse model did not display any of the pathologies that are apparent in CBS +/mice, indicating that HHcy elicits most of its effects through MMP-9. Moreover,
this study demonstrates that exercise training can completely mitigate most of
these physical and molecular changes found in CBS +/- mice.
In the second set of experiments, it was found that treatment of
macrophages with Hcy caused differentiation into a classically activated, M1
phenotype, which is associated with increased MMP-9 and ROS production. It
appears that HHcy induction of the M1 phenotype is EMMPRIN dependent, since
EMMPRIN induction prevented the M1 switch. Furthermore, this study
demonstrated that CBS +/- mice have a greater concentration of macrophages in
their skeletal muscle and that a great number of these macrophages were of the
M1 phenotype. Although exercise did not significantly decrease the total
macrophage concentration within the skeletal muscle, it was able to significantly
reduce the number of M1 macrophages present, indicating a lower state of
inflammation and adverse remodeling. Although the data is significant and
conclusive, our study was limited. A longer exercise protocol as well as different
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modalities of exercise would help make greater comparisons for this study. Also,
macrophages were not isolated from the skeletal muscle, so limited conclusions
could be made based on the IHC for co-localization of F4/80 and TNF-α for
indication of M1 macrophages. Isolation of macrophages from the skeletal
muscle could lead to more conclusive data.

Future Directions:
Skeletal muscle remodeling involves a great number of cell types and
secreted factors that regulate growth, repair and fibrosis of the skeletal muscle
ECM. The primary focus of this study was to determine if HHcy promotes
skeletal muscle fibrosis through induction of MMP-9 and the M1 macrophage
phenotype and whether or not exercise can mitigate the effects of HHcy.
Although this study was able to demonstrate these effects, there are many other
factors and signaling pathways that need to be determined to devise the
mechanism through which HHcy causes skeletal muscle dysfunction.
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